Franco Locatelli
#97,112
Most Influential Person Now
Researcher
Franco Locatelli's AcademicInfluence.com Rankings
Franco Locatellimedical Degrees
Medical
#1076
World Rank
#1373
Historical Rank
Pharmacology
#77
World Rank
#100
Historical Rank
Download Badge
Medical Biology
Franco Locatelli's Degrees
- PhD Biomedical Sciences University of Milan
- Bachelors Biology University of Bologna
Similar Degrees You Can Earn
Why Is Franco Locatelli Influential?
(Suggest an Edit or Addition)Franco Locatelli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study (2008) (2478)
- Outcome of cord-blood transplantation from related and unrelated donors (1997) (1244)
- Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. (2010) (697)
- Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. (2007) (691)
- Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. (2005) (611)
- Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. (2003) (557)
- Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. (2007) (526)
- Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. (1997) (522)
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. (2020) (449)
- Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study (2020) (413)
- Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia. (2016) (409)
- Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. (2004) (397)
- Chronic myelomonocytic leukemia in childhood. A retrospective analysis of 110 cases. (1997) (386)
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. (2009) (380)
- Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. (2003) (368)
- HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. (2014) (362)
- Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. (2011) (356)
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. (2016) (342)
- Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease (2011) (340)
- Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. (2017) (307)
- Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. (2008) (307)
- Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia (2010) (303)
- Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. (2005) (301)
- Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel (2014) (288)
- Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease (2001) (279)
- Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. (2009) (275)
- Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. (2016) (274)
- Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. (2003) (274)
- How I treat relapsed childhood acute lymphoblastic leukemia. (2012) (269)
- Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. (2002) (266)
- Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. (2005) (260)
- Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Tra (2000) (256)
- Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. (2015) (245)
- Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry (2004) (244)
- Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. (2014) (241)
- Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) (1997) (238)
- Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? (2012) (238)
- Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. (2011) (226)
- Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. (2020) (226)
- Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion. (2017) (225)
- Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. (2008) (222)
- Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade III–IV acute graft‐versus‐host disease (2013) (219)
- Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. (1998) (218)
- Prospective Monitoring of Polyomavirus BK Replication and Impact of Pre‐Emptive Intervention in Pediatric Kidney Recipients (2007) (216)
- Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. (2007) (216)
- Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications (2019) (216)
- Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis (2005) (214)
- Imatinib for refractory chronic graft-versus-host disease with fibrotic features. (2009) (213)
- Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. (2001) (211)
- Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. (2013) (210)
- Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses (2020) (210)
- Antilymphocyte globulin, cyclosporin, and granulocyte colony- stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party (1995) (206)
- Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study (2017) (205)
- Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. (2002) (203)
- γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes. (2015) (202)
- Preemptive Therapy of EBV‐Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation (2007) (200)
- Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantation (2003) (194)
- Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. (2016) (194)
- Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party (2010) (194)
- Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation (2019) (193)
- Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology. (2002) (193)
- GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. (2005) (191)
- Inhibition of Natural Killer Cell Cytotoxicity by Interleukin‐6: Implications for the Pathogenesis of Macrophage Activation Syndrome (2015) (189)
- A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. (2003) (185)
- A proportion of patients with lymphoma may harbor mutations of the perforin gene. (2004) (184)
- Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. (2005) (184)
- Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches (2003) (183)
- Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. (2005) (180)
- Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. (2003) (180)
- Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality (1999) (180)
- Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. (2001) (179)
- Mesenchymal Stromal Cells (2009) (175)
- SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. (2005) (171)
- Systematic identification of edited microRNAs in the human brain (2012) (167)
- How I treat juvenile myelomonocytic leukemia. (2015) (167)
- Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia (2010) (167)
- Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. (2012) (163)
- Human Cytomegalovirus Infection Promotes Rapid Maturation of NK Cells Expressing Activating Killer Ig–like Receptor in Patients Transplanted with NKG2C−/− Umbilical Cord Blood (2014) (159)
- The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. (2009) (156)
- Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. (2013) (156)
- Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial. (2000) (155)
- Extracorporeal photochemotherapy for treatmentof acute and chronic GVHD in childhood (2001) (154)
- Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. (2001) (154)
- Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial (2015) (154)
- Risk Factors and Severe Outcome in Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem Cell Transplantation (2006) (150)
- Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy (2013) (150)
- Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. (2000) (148)
- Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? (2012) (148)
- Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft‐versus‐host disease following allogeneic hematopoietic stem cell transplantation (2007) (144)
- Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. (2007) (142)
- The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation (2018) (141)
- An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. (2016) (139)
- Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. (2007) (138)
- Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. (2007) (137)
- Unrelated Bone Marrow Transplantation for β‐Thalassemia Patients: The Experience of the Italian Bone Marrow Transplant Group (2005) (137)
- Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. (2003) (137)
- Anti‐CD20 monoclonal antibody (Rituximab) for life‐threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus (2002) (137)
- Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study. (2019) (137)
- Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells. (2015) (135)
- Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children – a Eurocord analysis (2001) (130)
- Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. (2002) (129)
- A moderate transfusion regimen may reduce iron loading in beta‐ thalassemia major without producing excessive expansion of erythropoiesis (1997) (128)
- Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes (2017) (127)
- Allogeneic blood stem cell transplantation after a reduced‐intensity, preparative regimen (2002) (126)
- Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. (2006) (126)
- Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. (2009) (125)
- Neuroblastoma-Derived TGF-β1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells (2013) (125)
- Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity. (1999) (125)
- Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma (2015) (124)
- Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. (2002) (124)
- KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. (2014) (124)
- Analysis of immune reconstitution in children undergoing cord blood transplantation. (2001) (124)
- Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases (2020) (123)
- Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications (2014) (122)
- Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. (1995) (122)
- CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype. (2013) (121)
- Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry (2016) (119)
- Human NK cells: from HLA class I‐specific killer Ig‐like receptors to the therapy of acute leukemias (2008) (119)
- ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis (2012) (118)
- transplants in children with acute leukemia Comparison of outcomes of unrelated bone marrow and umbilical cord blood (2011) (118)
- Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors (2009) (117)
- Treatment of EBV‐Related Post‐Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV‐Specific T Cells (2005) (116)
- Cell therapy: achievements and perspectives. (1999) (116)
- Relationship between transfusion regimen and suppression of erythropoiesis in β‐thalassaemia major (1995) (116)
- Polyomavirus BK-specific immunity after kidney transplantation. (2004) (115)
- Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial. (2021) (115)
- Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTY (1991) (114)
- A Prospective, Multicenter Study of Caspofungin for the Treatment of Documented Candida or Aspergillus Infections in Pediatric Patients (2009) (114)
- Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. (2010) (113)
- The immune system of children: the key to understanding SARS-CoV-2 susceptibility? (2020) (113)
- Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients (2009) (112)
- Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. (1997) (112)
- HLA allele frequencies and susceptibility to COVID‐19 in a group of 99 Italian patients (2020) (112)
- Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. (2013) (112)
- Extracorporeal photochemotherapy in graft‐versus‐host disease: a longitudinal study on factors influencing the response and survival in pediatric patients (2010) (111)
- Italian cancer figures, report 2012: Cancer in children and adolescents. (2013) (111)
- Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study (2020) (110)
- Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells (2013) (108)
- NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia. (2018) (106)
- Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors (2014) (106)
- Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. (2014) (106)
- Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation (2007) (105)
- Stem cell transplantation for chronic myeloid leukemia in children. (2003) (104)
- A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function (2019) (104)
- Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. (2006) (100)
- Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. (2021) (99)
- Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association. (1995) (98)
- Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo). (1996) (98)
- CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment (2017) (98)
- Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma (2015) (97)
- Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II. (2002) (97)
- Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. (2010) (96)
- Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma (2018) (95)
- A-to-I RNA editing: the "ADAR" side of human cancer. (2012) (94)
- Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation (1999) (94)
- Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy. (2016) (91)
- Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma. (2004) (91)
- Ex vivo expansion of mesenchymal stromal cells. (2011) (90)
- Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. (2011) (89)
- Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia (2011) (88)
- ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion (2017) (87)
- Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia (2009) (86)
- PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance (2016) (86)
- Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. (1999) (85)
- Somatic PTPN11 mutations in childhood acute myeloid leukaemia (2005) (85)
- Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation. (2013) (85)
- Natural killer cells in the treatment of high-risk acute leukaemia. (2014) (85)
- Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis. (2016) (84)
- Clofarabine, cyclophosphamide and etoposide as single‐course re‐induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia (2009) (84)
- Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. (1999) (84)
- Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study (2011) (84)
- Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma (2013) (84)
- Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. (2003) (83)
- The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation (2019) (82)
- Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. (2007) (82)
- Invariant NKT Cell Reconstitution in Pediatric Leukemia Patients Given HLA-Haploidentical Stem Cell Transplantation Defines Distinct CD4+ and CD4− Subset Dynamics and Correlates with Remission State (2011) (82)
- NK cells and ILCs in tumor immunotherapy. (2020) (82)
- Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15–20% of cases (2002) (81)
- B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. (2005) (81)
- Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome (2020) (81)
- Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. (2000) (81)
- PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma (2017) (81)
- Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies (2016) (80)
- A novel self-lipid antigen targets human T cells against CD1c+ leukemias (2014) (80)
- Difference in Outcome of Adolescents with Acute Lymphoblastic Leukemia (ALL) Enrolled in Pediatric (AIEOP) and Adult (GIMEMA) Protocols. (2004) (80)
- Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study. (2010) (80)
- Haematopoetic stem cell transplantation for refractory autoimmune cytopenia (2004) (80)
- Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology–bone marrow transplantation group (2003) (80)
- Late pulmonary sequelae after childhood bone marrow transplantation (1999) (79)
- Molecular and clinical heterogeneity in CLCN7‐dependent osteopetrosis: report of 20 novel mutations (2010) (79)
- Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience. (2014) (79)
- Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma. (2004) (79)
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia (2013) (79)
- Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS (2017) (78)
- Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches (2014) (78)
- Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients (2007) (78)
- Minimal residual disease is an important predictive factor of outcome in children with relapsed ‘high-risk’ acute lymphoblastic leukemia (2008) (77)
- Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemia. (2018) (76)
- Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling (2014) (76)
- Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent (2014) (75)
- Modeling medulloblastoma in vivo and with human cerebellar organoids (2020) (75)
- Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. (2003) (75)
- Human Cytomegalovirus Immediate-Early mRNA Detection by Nucleic Acid Sequence-Based Amplification as a New Parameter for Preemptive Therapy in Bone Marrow Transplant Recipients (2000) (75)
- Extracorporeal photopheresis for the treatment of acute and chronic graft‐versus‐host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process (2013) (74)
- Activating and inhibitory killer immunoglobulin‐like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high‐risk leukaemias (2009) (74)
- Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. (2010) (74)
- Genomic subtyping and therapeutic targeting of acute erythroleukemia (2019) (73)
- Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children. (1996) (73)
- Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. (2008) (72)
- Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference. (2009) (72)
- Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP) (2008) (71)
- ADARs: allies or enemies? The importance of A‐to‐I RNA editing in human disease: from cancer to HIV‐1 (2012) (71)
- Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study. (2014) (71)
- Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing. (2011) (71)
- The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies. (2012) (70)
- RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia (2017) (70)
- HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2). (2004) (70)
- Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation (2014) (70)
- Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing (2019) (69)
- Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. (2003) (69)
- Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer (2012) (69)
- Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma (2020) (69)
- Lung function abnormalities after bone marrow transplantation in children: has the trend recently changed? (2001) (68)
- Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy (2001) (68)
- Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients (1995) (68)
- Donor/recipient mixed chimerism does not predict graft failure in children with β-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling (2008) (67)
- Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function. (2006) (67)
- Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model (2018) (67)
- Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients (2015) (66)
- t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients (2014) (66)
- Ethical reappraisal of 15 years of cord-blood transplantation (2003) (66)
- Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations. (2008) (66)
- Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma. (1997) (66)
- The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx) (2014) (66)
- Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study. (2016) (66)
- Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease. (2006) (65)
- Marriage and parenthood among childhood cancer survivors: a report from the Italian AIEOP Off-Therapy Registry (2011) (65)
- Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. (2018) (65)
- Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia (2014) (65)
- Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease. (2009) (65)
- Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors (2014) (64)
- Treosulfan‐based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease (2015) (64)
- An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019 (2020) (64)
- Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients. (1996) (63)
- ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors. (2015) (62)
- IRF1 and NF-kB Restore MHC Class I-Restricted Tumor Antigen Processing and Presentation to Cytotoxic T Cells in Aggressive Neuroblastoma (2012) (62)
- Open issues in Mucopolysaccharidosis type I-Hurler (2017) (62)
- Adolescents with cancer in Italy: entry into the national cooperative paediatric oncology group AIEOP trials. (2009) (61)
- Incidence and pathogenesis of tumor lysis syndrome. (2005) (60)
- Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML. (2012) (60)
- AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity (2021) (60)
- The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group (2007) (60)
- Atypical features of familial hemophagocytic lymphohistiocytosis. (2004) (60)
- Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (2018) (60)
- Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS (2014) (60)
- Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). (2009) (60)
- A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood. (1997) (60)
- How I treat myelodysplastic syndromes of childhood. (2018) (60)
- Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. (2015) (59)
- The human leucocyte antigen‐G 14‐basepair polymorphism correlates with graft‐versus‐host disease in unrelated bone marrow transplantation for thalassaemia (2007) (59)
- Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy. (2001) (59)
- Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease. (2011) (59)
- Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. (2014) (59)
- Treosulfan‐based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major (2008) (59)
- Constitutional trisomy 8 as first mutation in multistep carcinogenesis: Clinical, cytogenetic, and molecular data on three cases (1996) (59)
- The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman‐Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies (2009) (58)
- Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study. (2015) (58)
- Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry (2014) (57)
- Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations (2007) (57)
- SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best (2021) (57)
- Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). (2017) (57)
- Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (2020) (56)
- Notch1 regulates chemotaxis and proliferation by controlling the CC‐chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia (2012) (56)
- T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results. (2012) (56)
- Monitoring of Human Cytomegalovirus and Virus-Specific T-Cell Response in Young Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (2012) (56)
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma (2012) (56)
- Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO) (1997) (56)
- The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory. (2020) (56)
- Umbilical cord blood transplants (2000) (55)
- Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation (1995) (55)
- Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapse (2013) (54)
- NK Cell-Based Immunotherapy for Hematological Malignancies (2019) (54)
- COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection (2020) (54)
- ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism (2021) (54)
- Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes. (2005) (53)
- Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. (2004) (53)
- Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma. (2005) (53)
- Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma. (2018) (52)
- ADARs and the Balance Game between Virus Infection and Innate Immune Cell Response. (2015) (52)
- Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation. (2016) (52)
- Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy. (2006) (52)
- Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia (2019) (52)
- Acute Myeloid Leukemia in Infants: Biology and Treatment (2015) (52)
- Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). (2014) (52)
- The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood (2017) (52)
- Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA (2021) (52)
- Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings. (1999) (51)
- Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcome without original allograft nephrectomy. (2003) (51)
- Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21Cip1 expression and hampers tumour cell growth in vitro and in vivo (2011) (50)
- Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency. (2016) (50)
- Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine‐based reduced‐intensity conditioning regimen (2002) (50)
- Eomesodermin controls a unique differentiation program in human IL‐10 and IFN‐γ coproducing regulatory T cells (2018) (50)
- Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing (2003) (50)
- Extracorporeal membrane oxygenation in pediatric recipients of hematopoietic stem cell transplantation: an updated analysis of the Extracorporeal Life Support Organization experience (2014) (50)
- Prognostic significance of flow‐cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP‐AML 2002/01 study protocol (2017) (50)
- Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysis (2012) (49)
- Interleukin-27 Inhibits the Growth of Pediatric Acute Myeloid Leukemia in NOD/SCID/Il2rg−/− Mice (2012) (49)
- Stem cell transplantation from HLA‐matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP)–Gruppo Italiano Trapianto di Midollo Osseo (GITMO) (2001) (49)
- Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells (2014) (49)
- Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus. (2009) (48)
- HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia. (2014) (48)
- EZH2 Down-Regulation Exacerbates Lipid Accumulation and Inflammation in in Vitro and in Vivo NAFLD (2013) (48)
- Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. (2006) (48)
- Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation. (2006) (48)
- Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency. (2019) (48)
- Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor (c-mpl gene) in congenital amegakaryocytic thrombocytopenia (CAMT) (2000) (48)
- At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies (2013) (47)
- Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies (2013) (47)
- Kinetics of Epstein-Barr Virus DNA Load in Different Blood Compartments of Pediatric Recipients of T-Cell-Depleted HLA-Haploidentical Stem Cell Transplantation (2008) (47)
- Germ‐line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia (2009) (47)
- Disposition of high‐dose busulfan in pediatric patients undergoing bone marrow transplantation (1993) (47)
- Dexamethasone in Induction Can Eliminate One Third of All Relapses in Childhood Acute Lymphoblastic Leukemia (ALL): Results of An International Randomized Trial in 3655 Patients (Trial AIEOP-BFM ALL 2000) (2008) (47)
- Characterisation of CTL directed towards non-inherited maternal alloantigens in human cord blood (1999) (46)
- Myelodysplastic syndromes: recent advances. (2001) (46)
- MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality (2011) (46)
- Late effects in children after bone marrow transplantation: a review. (1993) (46)
- Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. (2004) (46)
- No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission. (2011) (46)
- Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel (1998) (46)
- MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte–macrophage maturation in AML-M5 THP-1 cells (2003) (46)
- Incidence of, and Risk Factors for, Nosocomial Infections Among Hematopoietic Stem Cell Transplantation Recipients, With Impact on Procedure-Related Mortality (2001) (46)
- Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A. (1993) (45)
- Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma (2019) (45)
- T-cell Lines Specific for Peptides of Adenovirus Hexon Protein and Devoid of Alloreactivity Against Recipient Cells can be Obtained From HLA-haploidentical Donors (2008) (45)
- Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation. (2017) (45)
- Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT (2019) (45)
- Selective autophagy maintains centrosome integrity and accurate mitosis by turnover of centriolar satellites (2018) (45)
- HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes. (1993) (45)
- Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders (2019) (45)
- T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant. (2008) (45)
- Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. (2017) (45)
- Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation (2002) (44)
- Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2 (2017) (44)
- Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections (2022) (44)
- Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia (1998) (44)
- An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. (2018) (44)
- Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement (2015) (43)
- Zoledronic acid boosts γδ T-cell activity in children receiving αβ+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor (2016) (43)
- Pre‐ and post‐transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia (2018) (43)
- The Yin and Yang of non-neuronal α7-nicotinic receptors in inflammation and autoimmunity. (2012) (43)
- Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (2021) (43)
- Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood (2009) (43)
- Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment. (2010) (42)
- Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease (2012) (42)
- Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behcet disease. (2004) (42)
- Impact of HCMV Infection on NK Cell Development and Function after HSCT (2013) (42)
- Transplant of bone marrow and cord blood hematopoietic stem cells in pediatric practice, revisited according to the fundamental principles of bioethics (1997) (41)
- Correction to: HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy (2019) (41)
- Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease (2019) (41)
- Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL. (2018) (41)
- Robot-Assisted Stereotactic Biopsy of Diffuse Intrinsic Pontine Glioma: A Single-Center Experience. (2017) (41)
- β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells (2017) (41)
- Rituximab (anti-cd20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment (2006) (41)
- Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in β‐thalassemia (2010) (40)
- Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study (2009) (40)
- Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft‐versus‐host disease in oncohaematological paediatric patients (2010) (40)
- Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen (2014) (40)
- Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease (2012) (40)
- Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy. (2018) (39)
- TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells (2015) (39)
- High frequency of Epstein–Barr virus (EBV) lymphoblastoid cell line‐reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL‐2 production (1997) (39)
- Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias (2018) (39)
- Allogeneic bone marrow transplantation versus chemotherapy in high‐risk childhood acute lymphoblastic leukaemia in first remission (1997) (39)
- Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation (2011) (39)
- An outbreak of extremely drug-resistant Pseudomonas aeruginosain a tertiary care pediatric hospital in Italy (2014) (39)
- Diamond‐Blackfan anaemia in the Italian population (1999) (39)
- Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? (2012) (39)
- Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway (2016) (39)
- Resolution of immune haemolytic anaemia with allogeneic bone marrow transplantation after an unsuccessful autograft (1999) (39)
- A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children (2020) (39)
- ADAR Enzyme and miRNA Story: A Nucleotide that Can Make the Difference (2013) (39)
- Targeting Multiple-Myeloma-Induced Immune Dysfunction to Improve Immunotherapy Outcomes (2012) (39)
- Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective. (2017) (39)
- MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia. (2014) (39)
- Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies (2020) (38)
- Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics (2014) (38)
- Haematopoietic Cell Transplantation in Chronic Granulomatous Disease: a Study on 712 Children and Adults. (2020) (38)
- Outcome of very late relapse in children with acute lymphoblastic leukemia. (2004) (38)
- Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders? (2007) (38)
- Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia (2015) (38)
- Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT. (2010) (38)
- Role of non‐HLA genetic polymorphisms in graft‐versus‐host disease after haematopoietic stem cell transplantation (2006) (38)
- Growth in children after bone marrow transplantation. (1993) (38)
- Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages (2017) (38)
- NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation (2016) (37)
- Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group (2015) (37)
- Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias (2016) (37)
- The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activity (2017) (37)
- Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation (2019) (37)
- Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism. (2013) (37)
- Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study (2020) (37)
- Mesenchymal stromal cell infusions as rescue therapy for corticosteroid-refractory adult autoimmune enteropathy. (2012) (37)
- Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group. (2018) (37)
- Hematopoietic stem-cell transplantation for the Bernard-Soulier syndrome. (2003) (37)
- A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study). (2020) (36)
- Human NK receptors: From the molecules to the therapy of high risk leukemias (2011) (36)
- Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. (2005) (36)
- Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood (2014) (36)
- Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB (2015) (36)
- Proteomic Analysis of Neuroblastoma‐Derived Exosomes: New Insights into a Metastatic Signature (2017) (36)
- Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome. (1994) (36)
- Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood (2014) (36)
- Mutations in the erythropoietin receptor gene are not a common cause of Diamond-Blackfan anemia. (1996) (35)
- The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G‐CSF (2016) (35)
- Early and progressive insulin resistance in young, non‐obese cancer survivors treated with hematopoietic stem cell transplantation (2015) (35)
- Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia. (2006) (35)
- Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene (2017) (35)
- Cyclooxygenase-2 (COX-2) Inhibition Constrains Indoleamine 2,3-Dioxygenase 1 (IDO1) Activity in Acute Myeloid Leukaemia Cells (2013) (35)
- Human NK cells: From surface receptors to clinical applications. (2016) (35)
- Homozygosity for human leucocyte antigen‐C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen‐C‐matched unrelated donor haematopoietic stem cell transplantation (2005) (35)
- CBFA2T3‐GLIS2‐positive acute myeloid leukaemia. A peculiar paediatric entity (2018) (35)
- T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation. (2004) (34)
- Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis (2018) (34)
- Busulfan (1994) (34)
- Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma (2017) (34)
- Remestemcel-L for the treatment of graft versus host disease (2017) (34)
- Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia (2014) (34)
- Long‐term results of high‐dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience (2015) (34)
- BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas (2018) (34)
- Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy (2017) (33)
- The impact of paediatric bone marrow transplantation on quality of life (1995) (33)
- Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies (2019) (33)
- Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. (2019) (33)
- Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission. (2003) (33)
- The miR‐139‐5p regulates proliferation of supratentorial paediatric low‐grade gliomas by targeting the PI3K/AKT/mTORC1 signalling (2018) (33)
- Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia (2019) (33)
- Familial platelet disorder with propensity to acute myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies (2004) (33)
- Human innate lymphoid cells. (2016) (33)
- Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry. (1996) (33)
- MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential. (2017) (33)
- Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation (2019) (33)
- Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors. (1995) (32)
- Unrelated hematopoietic stem cell transplantation for Cernunnos‐XLF deficiency (2009) (32)
- Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults (2014) (32)
- Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement (2015) (32)
- T and NK cells: two sides of tumor immunoevasion (2013) (32)
- RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia (2014) (32)
- Human Bone Marrow-Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-Term In Vitro Culture and Do Not Exhibit Telomere Maintenance Mechanisms. (2007) (32)
- COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection (2020) (32)
- COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study (2020) (31)
- CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T cells (2020) (31)
- Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients (2017) (31)
- The RNA editing enzymes ADARs: mechanism of action and human disease (2014) (31)
- NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (2017) (31)
- Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant. (2019) (31)
- Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor. (2012) (31)
- Survival of children with cancer in Italy, 1989-98. A report from the hospital based registry of the Italian Association of Paediatric Haematology and Oncology (AIEOP). (2008) (31)
- High‐dose vincristine, fractionated total‐body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7‐year Italian multicentre study (1995) (31)
- Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts (2014) (31)
- Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications (2011) (31)
- Stem cell transplantation for aplastic anemia and myelodysplastic syndrome (2005) (30)
- Late Development of FcεRγneg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients (2018) (30)
- Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia. (2021) (30)
- On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies. (2011) (30)
- Endoplasmic reticulum aminopeptidase 1 function and its pathogenic role in regulating innate and adaptive immunity in cancer and major histocompatibility complex class I-associated autoimmune diseases. (2014) (30)
- MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma (2017) (30)
- Successful In Vitro Priming of EBV‐Specific CD8+ T Cells Endowed with Strong Cytotoxic Function from T Cells of EBV‐Seronegative Children (2006) (30)
- A Phase 1/2 Study Of Blinatumomab In Pediatric Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (2013) (30)
- Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry (2013) (30)
- Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. (2016) (29)
- Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation (2009) (29)
- Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. (2004) (29)
- CB(2) and TRPV(1) receptors oppositely modulate in vitro human osteoblast activity. (2015) (29)
- Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients. (2010) (29)
- The changing role of stem cell transplantation in childhood (2008) (29)
- Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). (2000) (29)
- B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies (2021) (29)
- Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. (2006) (29)
- Immune Reconstitution and Early Infectious Complications Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (2003) (29)
- IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma (2016) (29)
- Isolation and ex vivo expansion of bone marrow-derived porcine mesenchymal stromal cells: potential for application in an experimental model of solid organ transplantation in large animals. (2010) (29)
- Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children (2014) (29)
- RNA editing signature during myeloid leukemia cell differentiation (2017) (29)
- Kaposi's Sarcoma in a child after autologous bone marrow transplantation for non‐Hodgkin's lymphoma (1991) (28)
- Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients. (2007) (28)
- Biological, Functional and Genetic Characterization of Bone Marrow-Derived Mesenchymal Stromal Cells from Pediatric Patients Affected by Acute Lymphoblastic Leukemia (2013) (28)
- Tetralogy of Fallot is an Uncommon Manifestation of Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome (2012) (28)
- Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro. (1995) (28)
- Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study. (2021) (28)
- Transplant-related toxicity and mortality: an AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia (2002) (28)
- Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group. (2019) (28)
- Donor–recipient incompatibility at CD31‐codon 563 is a major risk factor for acute graft‐versus‐host disease after allogeneic bone marrow transplantation from a human leucocyte antigen‐matched donor (2001) (28)
- Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation. (2009) (28)
- Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols (2019) (28)
- Interleukin-15 Favors the Expansion of Central Memory CD8+ T Cells in Ex Vivo Generated, Antileukemia Human Cytotoxic T Lymphocyte Lines (2008) (28)
- Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells (2020) (28)
- First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection. (2010) (27)
- Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow. (1998) (27)
- High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study (2017) (27)
- Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma (2021) (27)
- Phosphatidylinositol 3‐kinase inhibition potentiates glucocorticoid response in B‐cell acute lymphoblastic leukemia (2018) (27)
- Transplantation in the onco-hematology field: focus on the manipulation of αβ and γδ T cells. (2012) (27)
- Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma (2021) (27)
- Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets. (1995) (27)
- Improving cord blood transplantation in children (2009) (27)
- Ontogenic changes in hematopoietic hierarchy determine pediatric specificity and disease phenotype in fusion oncogene-driven myeloid leukemia. (2019) (27)
- Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells (2019) (27)
- Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors (2016) (26)
- Local control in metastatic neuroblastoma in children over 1 year of age (2015) (26)
- MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment (2016) (26)
- Adoptive immunotherapy with antigen‐specific T cells during extracorporeal membrane oxygenation (ECMO) for adenovirus‐related respiratory failure in a child given haploidentical stem cell transplantation (2014) (26)
- AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis. (2018) (26)
- Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (2014) (26)
- Transplantation for thalassemia major: alternative donors (2016) (26)
- Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donors. (2003) (26)
- Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation (2001) (26)
- Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy (2010) (26)
- Risk of seizures in children receiving busulphan-containing regimens for stem cell transplantation. (2014) (26)
- ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP (2019) (26)
- Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion. (2017) (26)
- Foxm1 controls a pro-stemness microRNA network in neural stem cells (2018) (26)
- The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients (2021) (26)
- Prolyl isomerase Pin1 and protein kinase HIPK2 cooperate to promote cortical neurogenesis by suppressing Groucho/TLE:Hes1-mediated inhibition of neuronal differentiation (2013) (26)
- Single-agent expansion cohort of lenvatinib (LEN) and combination dose-finding cohort of LEN + etoposide (ETP) + ifosfamide (IFM) in patients (pts) aged 2 to ≤25 years with relapsed/refractory osteosarcoma (OS). (2018) (25)
- Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy (1998) (25)
- Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol (2020) (25)
- Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding (2020) (25)
- Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation. (2014) (25)
- Phase 1/2 Study in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Receiving Blinatumomab Treatment (2014) (25)
- Bone marrow transplantation for inherited bone marrow failure syndromes. (2010) (25)
- Automated washing of human progenitor cells: evaluation of apoptosis and cell necrosis (2011) (25)
- A long‐term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients (2007) (25)
- Ex vivo generation and expansion of anti‐tumor cytotoxic T‐cell lines derived from patients or their HLA‐identical sibling (2004) (25)
- Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group. (1999) (25)
- Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches (2013) (25)
- A model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation (1999) (25)
- Neuroblastoma-secreted exosomes carrying miR‐375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells (2020) (24)
- Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic stem cell transplant in children: results of a prospective randomized trial. (2002) (24)
- Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation (2018) (24)
- Does the emergence and persistence of donor-derived leukaemia-reactive cytotoxic T lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study (1998) (24)
- Transplant of hematopoietic stem cells in childhood: where we are and where we are going. (1998) (24)
- Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti‐D immunoglobulins (1994) (24)
- Treatment with short‐term, high‐dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura (2003) (24)
- Reversible induction of mitophagy by an optogenetic bimodular system (2019) (24)
- Activation of an endothelial Notch1-Jagged1 circuit induces VCAM1 expression, an effect amplified by interleukin-1β (2015) (24)
- Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study (2010) (24)
- Role of allogeneic bone marrow transplantation from an HLA‐identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia (1996) (24)
- PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation (2019) (24)
- Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study (2020) (23)
- GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia. (2007) (23)
- Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency (2020) (23)
- Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy (2020) (23)
- Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498) (2008) (23)
- DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia (2013) (23)
- Multimodal Therapeutic Approach of Cytokine Release Syndrome Developing in a Child Given Chimeric Antigen Receptor-Modified T Cell Infusion (2020) (23)
- Iron overload enhances human mesenchymal stromal cell growth and hampers matrix calcification. (2016) (23)
- Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network (2019) (23)
- Reduced-intensity regimens in allogeneic hematopoietic stem cell transplantation for hemoglobinopathies. (2006) (23)
- Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation (2003) (23)
- Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup (2015) (22)
- Che‐1 is targeted by c‐Myc to sustain proliferation in pre‐B‐cell acute lymphoblastic leukemia (2018) (22)
- Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma (2015) (22)
- Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: Experience of two pediatric institutions (2008) (22)
- Accelerated erythroid repopulation with no stem‐cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation (1993) (22)
- Extracorporeal membrane oxygenation as a bridge to allogeneic T-cell depleted hematopoietic stem cell transplantation in infants with severe combined immune deficiency: is it feasible? (2014) (22)
- Vitiligo‐Like Lesions and Diffuse Lightening of the Skin in a Pediatric Patient Treated with Imatinib Mesylate: A Noninvasive Colorimetric Assessment (2006) (22)
- Canonical and Noncanonical Roles of Fanconi Anemia Proteins: Implications in Cancer Predisposition (2020) (22)
- Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms (2017) (22)
- CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia (2014) (22)
- Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing (2016) (21)
- Cysteamine treatment restores the in vitro ability to differentiate along the osteoblastic lineage of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient (2015) (21)
- The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukaemia relapsing following allogeneic transplantation (1998) (21)
- Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation. (2005) (21)
- Safety and Efficacy of Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis (2018) (21)
- Tolerance and hematopoietic stem cell transplantation 50 years after Burnet's theory. (2000) (21)
- Unpurged ABMT for neuroblastoma: AIEOP-BMT experience. (1991) (21)
- B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy (2016) (21)
- Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group (2020) (21)
- Immunization with Haemophilus influenzae Type b Conjugate Vaccine in Children Given Bone Marrow Transplantation: Comparison with Healthy Age-Matched Controls (1998) (21)
- Cord blood transplantation in patients with hemoglobinopathies. (2010) (21)
- Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study (2020) (21)
- Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group. (2012) (21)
- Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation. (2011) (20)
- Processing of hematopoietic stem cells from peripheral blood before cryopreservation: use of a closed automated system (2011) (20)
- Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumours. (2020) (20)
- Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission: first choice for isolated extramedullary relapse? (1994) (20)
- The Vici syndrome protein EPG5 regulates intracellular nucleic acid trafficking linking autophagy to innate and adaptive immunity (2018) (20)
- Hematopoietic Stem Cell Transplantation in Thalassemia. (2018) (20)
- Incompatibility for CD31 and human platelet antigens and acute graft‐versus‐host disease after bone marrow transplantation (1999) (20)
- ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas (2013) (20)
- Fatal pneumopathy in children after bone marrow transplantation--report from the Italian Registry. Italian Association of Pediatric Hematology-Oncology BMT Group. (1995) (20)
- Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: Results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial (2007) (20)
- Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs) (2017) (20)
- Oligophrenin-1 (OPHN1), a Gene Involved in X-Linked Intellectual Disability, Undergoes RNA Editing and Alternative Splicing during Human Brain Development (2014) (19)
- High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis, relapsed non-Hodgkin's lymphoma. (1993) (19)
- Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay (2020) (19)
- An Influence Diagram for Assessing GVHD Prophylaxis after Bone Marrow Transplantation in Children (1994) (19)
- Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia (2015) (19)
- Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction. (2006) (19)
- An Electronic Infrastructure for Research and Treatment of the Thalassemias and Other Hemoglobinopathies: The Euro-Mediterranean Ithanet Project (2009) (19)
- Reconstitution of multifunctional CD56lowCD16low natural killer cell subset in children with acute leukemia given α/β T cell-depleted HLA-haploidentical haematopoietic stem cell transplantation (2017) (19)
- Spinal osteomyelitis due to Aspergillus flavus in a child: a rare complication after haematopoietic stem cell transplantation (2008) (19)
- Notch signaling in pediatric soft tissue sarcomas (2012) (19)
- A single high dose of idarubicin combined with high‐dose ARA‐C for treatment of first relapse in childhood ‘high‐risk’ acute lymphoblastic leukaemia: a study of the AIEOP group (2002) (19)
- Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group (2016) (19)
- Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects. (2004) (19)
- Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients (2017) (19)
- Combined cord blood and bone marrow transplantation from the same human leucocyte antigen‐identical sibling donor for children with malignant and non‐malignant diseases (2015) (19)
- T(reg) cells: collection, processing, storage and clinical use. (2011) (18)
- Cytological and molecular remissions with blinatumomab treatment in second or later bone marrow relapse in pediatric acute lymphoblastic leukemia (ALL). (2013) (18)
- Targeting mesenchymal stromal cells plasticity to reroute acute myeloid leukemia course. (2021) (18)
- Recombinant human erythropoietin is effective in correcting erythropoietin‐deficient anaemia after allogeneic bone marrow transplantation (1992) (18)
- Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy. (2012) (18)
- Management of Graft-Versus-Host Disease in Paediatric Bone Marrow Transplant Recipients (2000) (18)
- Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study (2019) (18)
- Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia (2012) (18)
- Nelarabine in Combination with Etoposide and Cyclophosphamide Is Active in First Relapse of Childhood T-Acute Lymphocytic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL) (2014) (18)
- The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency (2022) (18)
- Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study. (2005) (18)
- Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases. (2012) (18)
- gd T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR- ab 1 /CD19 1 lymphocytes (2016) (18)
- New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies (2004) (18)
- Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia (2018) (18)
- Allogeneic Stem Cell Transplantation for Children With Acute Myeloid Leukemia in Second Complete Remission (2008) (18)
- Microbial Tracking of Multidrug-Resistant Klebsiella Pneumoniae Isolates in a Pediatric Hospital Setting (2013) (18)
- T lymphocytes against solid malignancies: winning ways to defeat tumours (2018) (17)
- Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection (2016) (17)
- Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome (2021) (17)
- Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias. (2010) (17)
- Upfront treatment with mTOR inhibitor everolimus in pediatric low‐grade gliomas: A single‐center experience (2020) (17)
- Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT) (2020) (17)
- Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab (2020) (17)
- Outcomes after Unrelated Umbilical Cord Blood Transplantation for Children with Osteopetrosis. (2016) (17)
- Modified chop‐chemotherapy plus rituximab for diffuse large b‐cell lymphoma complicating ataxia‐telangiectasia (2003) (17)
- Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. (2012) (17)
- Src nuclear localization and its prognostic relevance in human osteosarcoma (2018) (17)
- Cord blood transplantation for children with acute leukemia (1998) (17)
- Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis. (1999) (17)
- Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens (2017) (17)
- ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells (2018) (17)
- Delayed referral of pediatric brain tumors during COVID-19 pandemic (2020) (17)
- Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial. (2021) (17)
- Ewing Sarcoma of the Bone in Children under 6 Years of Age (2013) (17)
- Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses (2001) (17)
- Treatment of severe refractory acute graft-versus-host disease of the gastrointestinal tract with Campath-1H. (2005) (16)
- Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1 (2016) (16)
- Northstar-3: Interim Results from a Phase 3 Study Evaluating Lentiglobin Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia and Either a β0 or IVS-I-110 Mutation at Both Alleles of the HBB Gene (2019) (16)
- Ethics of creating programmed stem-cell donors (2000) (16)
- Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies (2020) (16)
- Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency (2017) (16)
- Somatic mutations activating Wiskott–Aldrich syndrome protein concomitant with RAS pathway mutations in juvenile myelomonocytic leukemia patients (2018) (16)
- COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial (2021) (16)
- The role of reduced intensity preparative regimens in patients with thalassemia given hematopoietic transplantation (2010) (16)
- Innovative approaches to hematopoietic stem cell transplantation for patients with thalassemia. (2005) (16)
- Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children (2020) (16)
- CB2 Receptor Stimulation and Dexamethasone Restore the Anti-Inflammatory and Immune-Regulatory Properties of Mesenchymal Stromal Cells of Children with Immune Thrombocytopenia (2019) (16)
- Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial (2015) (16)
- Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT (2021) (16)
- Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party. (2017) (16)
- Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation. (1994) (16)
- Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO). (1994) (16)
- Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies (2021) (16)
- Whole transcriptome sequencing of a paediatric case of de novo acute myeloid leukaemia with del(5q) reveals RUNX1‐USP42 and PRDM16‐SKI fusion transcripts (2014) (16)
- Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis. (1999) (16)
- Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD). (2014) (16)
- Allogeneic Hematopoietic Stem Cell Transplantation May Restore Gluten Tolerance in Patients With Celiac Disease (2013) (15)
- Diagnosis and monitoring of human cytomegalovirus infection in transplant recipients (2001) (15)
- Interactions between killer immunoglobulin‐like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm (2012) (15)
- Using uncertainty management techniques in medical therapy planning: A decision-theoretic approach (1998) (15)
- HLA-haploidentical TCRαβ+/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia. (2021) (15)
- Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation (2016) (15)
- Mesenchymal stromal cells and chronic inflammatory bowel disease. (2015) (15)
- Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant (2021) (15)
- Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML (2018) (15)
- Transcription factors involved in tumorigenesis are over-represented in mutated active DNA binding sites in neuroblastoma. (2019) (15)
- Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis (2022) (15)
- Isomorphic cutaneous graft‐versus‐host disease reaction after ultraviolet exposure: clinical, histological and direct immunofluorescence studies of four allo‐transplanted patients (2009) (15)
- Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features (2014) (15)
- Autologous bone marrow transplantation in children with acute myeloblastic leukemia: report from the Italian National Pediatric Registry (AIEOP-BMT). (1996) (15)
- Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP). (2012) (15)
- Successful medical treatment of EBV smooth muscle tumor in a renal transplant recipient (2010) (15)
- Arsenic trioxide and all‐trans retinoic acid treatment for childhood acute promyelocytic leukaemia (2018) (15)
- Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors. (2016) (15)
- Remission, treatment failure, and relapse in pediatric ALL: An international consensus of the Ponte-di-Legno Consortium. (2021) (15)
- Cord blood transplantation in children with haematological malignancies. (2010) (15)
- Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML (2020) (15)
- The clinical and biological characteristics of NUP98-KDM5A pediatric acute myeloid leukemia (2020) (15)
- Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia (2020) (15)
- Transplantation of cord blood progenitor cells can promote bone resorption in autosomal recessive osteopetrosis (1997) (15)
- Expression profiles of exosomal miRNAs isolated from plasma of patients with desmoplastic small round cell tumor. (2019) (15)
- GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes (2020) (14)
- Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patients. (2015) (14)
- Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment (2021) (14)
- Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention (2020) (14)
- DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study (2011) (14)
- Phase I-IIa Clinical Trial to Assess Safety and Efficacy of MLM-CAR44.1, a CD44v6 Directed CAR-T in Relapsed/Refractory Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM) (2018) (14)
- The prognostic value of biological markers in paediatric Hodgkin lymphoma. (2016) (14)
- Genetic prothrombotic factors in children with otogenic lateral sinus thrombosis: five case reports (2012) (14)
- Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC) (2020) (14)
- Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial (2019) (14)
- The Hoyeraal-Hreidarsson syndrome: the presentation of the seventh case. (1997) (14)
- Nutlin-3a Enhances Natural Killer Cell–Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors (2020) (14)
- Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia (2020) (14)
- Chronic lymphoid leukemia. Clinical observations about its natural progression. (1980) (14)
- A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation (2012) (14)
- Unexpected High Frequency of GATA2 Mutations in Children with Non-Familial MDS and Monosomy 7 (2012) (14)
- Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling (2021) (14)
- Vancomycin-resistant Enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation: clinical and microbiologic features. (2000) (14)
- Non‐myeloablative stem cell transplantation for severe combined immunodeficiency – Omenn syndrome (2004) (14)
- Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel (2016) (14)
- Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives (2020) (14)
- Low-Grade Gliomas in Patients with Noonan Syndrome: Case-Based Review of the Literature (2020) (14)
- Lentiglobin Gene Therapy for Patients with Transfusion-Dependent β-Thalassemia (TDT): Results from the Phase 3 Northstar-2 and Northstar-3 Studies (2018) (14)
- Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma. (2011) (14)
- Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency (2015) (13)
- Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantation. (2004) (13)
- Effect of corticoid therapy on growth hormone secretion. (1991) (13)
- Clinical grading of oral chronic graft-versus-host disease in 104 consecutive adult patients. (2005) (13)
- Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children (2020) (13)
- Haploidentical Haematopoietic Stem Cell Transplantation: Role of NK Cells and Effect of Cytomegalovirus Infections. (2016) (13)
- Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia. (2021) (13)
- Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT inborn errors working party analysis. (2022) (13)
- Efficacy and safety of recombinant urate oxidase (rasburicase) for treatment and prophylaxis of hyperuricemia in children undergoing chemotherapy. (2005) (13)
- TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders (2021) (13)
- Influence of the HLA characteristics of Italian patients on donor search outcome in unrelated hematopoietic stem cell transplantation. (2014) (13)
- Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children (2018) (13)
- Tolerogenic effect of mesenchymal stromal cells on gliadin-specific T lymphocytes in celiac disease. (2014) (13)
- Eltrombopag for treatment of thrombocytopenia-associated disorders (2015) (13)
- The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation (2005) (13)
- Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing (2015) (13)
- Cell kinetics of CD34‐positive hematopoietic cells following chemotherapy plus colony‐stimulating factors in advanced breast cancer (1995) (13)
- JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction (2020) (13)
- Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols (2020) (13)
- Targeting BAG-1: a novel strategy to increase drug efficacy in acute myeloid leukemia. (2015) (13)
- The role of interferon‐gamma and its signaling pathway in pediatric hematological disorders (2021) (13)
- Transplantation of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors: Robust Engraftment and Rapid Immune Reconstitution In Children with High Risk Leukemia (2011) (13)
- Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia. (2012) (13)
- Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia. (2002) (12)
- Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants (2021) (12)
- The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children. (2019) (12)
- Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia. (2009) (12)
- Philadelphia-Like Signature In Childhood Acute Lymphoblastic Leukemia: The AIEOP Experience (2013) (12)
- Sirolimus-related toxicity in stem cell transplantation. (2005) (12)
- Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. (2017) (12)
- Two novel cases of trilateral retinoblastoma: genetics and review of the literature. (2013) (12)
- Spectrum of innate and adaptive immune response to SARS CoV 2 infection across asymptomatic, mild and severe cases; a longitudinal cohort study (2020) (12)
- Pneumopathy in children after bone marrow transplantation. Report from the AIEOP-BMT Registry. The Italian Association of Pediatric Hematology-Oncology BMT Group. (1996) (12)
- Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress (2016) (12)
- Survey on haematopoietic stem cell transplantation for children in Europe (2005) (12)
- GIMEMA-AIEOP AIDA Protocols for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) In Children: Analysis of 247 Patients Enrolled In Two Sequential Italian Multicenter Trials (2010) (12)
- Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups (2017) (12)
- 6: A Multicentric Comparative Analysis of Outcomes of HLA Identical Related Cord Blood and Bone Marrow Transplantation in Patients With Beta-Thalassemia or Sickle Cell Disease (2008) (11)
- Phenotypic and Functional Characterization of NK Cells in αβT-Cell and B-Cell Depleted Haplo-HSCT to Cure Pediatric Patients with Acute Leukemia (2020) (11)
- Phase I combination dose-finding/phase II expansion cohorts of lenvatinib + etoposide + ifosfamide in patients (pts) aged 2 to ≤ 25 years with relapsed/refractory (r/r) osteosarcoma (2019) (11)
- Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia (2013) (11)
- Drug-mediated marrow purging: mafosfamide in adult acute leukemia in remission. The experience of the Italian study group. (1989) (11)
- Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation. (2016) (11)
- Reduced Intensity Delayed Intensification in Standard-Risk Patients Defined By Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Results of an International Randomized Trial in 1164 Patients (Trial AIEOP-BFM ALL 2000) (2016) (11)
- Effect of methylprednisolone in patients with Guillain-Barré syndrome (2004) (11)
- Bartonella‐related pseudomembranous angiomatous papillomatosis of the oral cavity associated with allogeneic bone marrow transplantation and oral graft‐versus‐host disease (2007) (11)
- Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management (2021) (11)
- Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor and Molecularly Resistant Acute Lymphoblastic Leukemia (R/R ALL): Updated Analysis of 110 Patients Treated in an Expanded Access Study (RIALTO) (2019) (11)
- Innate lymphoid cells in normal and disease: An introductory overview. (2016) (11)
- Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia and Non-β0/β0 Genotypes (2019) (11)
- Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome (2021) (11)
- Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas (2021) (11)
- In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study (2013) (11)
- Epigenetic Deregulation of MicroRNAs in Rhabdomyosarcoma and Neuroblastoma and Translational Perspectives (2012) (11)
- Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study. (2019) (11)
- Results from an international phase 2 study of the anti‐CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B‐lineage acute lymphoblastic leukemia (2020) (11)
- GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape (2021) (11)
- Unmanipulated Donor Lymphocytes for EBV-Related PTLD After T-Cell Depleted HLA-Haploidentical Transplantation (2012) (11)
- Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014. (2016) (11)
- T‐cell depleted HLA‐haploidentical HSCT in a child with neuromyelitis optica (2019) (11)
- Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias". (1992) (11)
- High-Resolution Array CGH Profiling Identifies Na/K Transporting ATPase Interacting 2 (NKAIN2) as a Predisposing Candidate Gene in Neuroblastoma (2013) (11)
- Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma. (2022) (11)
- Treatment of disease recurrence after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A great challenge still to be won (2013) (11)
- Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO). (2002) (11)
- TFG binds LC3C to regulate ULK1 localization and autophagosome formation (2021) (11)
- Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies (2020) (10)
- Lessons from the COVID-19 Pandemic—Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe’s Public Health Systems (2020) (10)
- Time to evolve: predicting engineered T cell-associated toxicity with next-generation models (2022) (10)
- Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior. (2013) (10)
- Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency (2021) (10)
- Hyper-Activation of Notch3 Amplifies the Proliferative Potential of Rhabdomyosarcoma Cells (2014) (10)
- The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment (2021) (10)
- Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). (1997) (10)
- Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era (2020) (10)
- Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting (2018) (10)
- Report of a child with vitiligo and Evans syndrome. (2003) (10)
- Quantitative ultrasound detects bone impairment after bone marrow transplantation in children and adolescents affected by hematological diseases. (2008) (10)
- Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: gut microbiota profiling, infectious and clinical outcomes. (2020) (10)
- Will post-transplantation cell therapies for pediatric patients become standard of care? (2015) (10)
- In vivo T‐cell depletion with pretransplant low‐dose antithymocyte globulin is associated with reduced transplant‐related mortality and improved clinical outcome in patients receiving allogeneic hematopoietic stem cell transplantation from unrelated and partially matched related donors (2011) (10)
- Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation (2008) (10)
- Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (2022) (10)
- Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. (2000) (10)
- Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators (2021) (10)
- Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL) (2020) (10)
- Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study (2022) (10)
- Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III. (2021) (10)
- MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs (2016) (10)
- PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients (2019) (10)
- Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group. (2013) (9)
- Identification of neuroblastoma cell lines with uncommon TAZ+/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells (2021) (9)
- Gonadal and uterine function in female survivors treated by chemotherapy, radiotherapy, and/or bone marrow transplantation for childhood malignant and non‐malignant diseases (2014) (9)
- Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. (2010) (9)
- MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells (2021) (9)
- RECURRENT GENETIC FUSIONS REDEFINE MLL-GERMLINE ACUTE LYMPHOBLASTIC LEUKEMIA IN INFANTS. (2020) (9)
- Burkitt lymphoma in a patient with Kabuki syndrome carrying a novel KMT2D mutation (2019) (9)
- Isoniazid-induced pure red cell aplasia in two siblings. (1998) (9)
- Congenital aggressive variant of Langerhans cells histiocytosis with CD56+/E‐Cadherin− phenotype (2009) (9)
- Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet) (2019) (9)
- Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity (2019) (9)
- Overview of T-cell depletion in haploidentical stem cell transplantation. (2012) (9)
- Successful bone marrow transplantation in children with severe aplastic anemia using HLA‐partially matched family donors (1993) (9)
- De Novo A-to-I RNA Editing Discovery in lncRNA (2020) (9)
- Childhood Leukemias: Chronic myeloproliferative disorders (2006) (9)
- Results from the Hgb-207 (Northstar-2) Trial: A Phase 3 Study to Evaluate Safety and Efficacy of Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia (TDT) in Patients with Non-β0/β0 Genotypes (2017) (8)
- OUTCOME of Unrelated DONOR BONE MARROW TRANSPLANTATION for THALASSEMIA MAJOR PATIENTS (2011) (8)
- Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I‐BFM analysis of 333 children (2020) (8)
- Alternative Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Europe (2018) (8)
- Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation (2019) (8)
- Allogeneic transplantation of peripheral blood progenitor cells in children: experience of two pediatric centers. (1998) (8)
- Vemurafenib Treatment of Pleomorphic Xanthoastrocytoma in a Child With Down Syndrome (2019) (8)
- Expression of p75 chain of IL‐2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation (1994) (8)
- Cellular immunotherapy for viral infections in solid organ transplant recipients (2002) (8)
- Functional depletion of T cells by vincristine and methylprednisolone as an in vitro model for the prevention of graft versus host disease. (1992) (8)
- Radiogenomics prediction for MYCN amplification in neuroblastoma: A hypothesis generating study (2021) (8)
- Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study (2015) (8)
- Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004. (2004) (8)
- Response to comment on Multifunctional human CD56lowCD16low NK cells are the prominent subset in bone marrow of both pediatric healthy donors and leukemic patients (2015) (8)
- Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies (2021) (8)
- Current and future role of bispecific T-cell engagers in pediatric acute lymphoblastic leukemia (2018) (8)
- Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation. (2005) (8)
- TRANSPLANTATION Outcome of children with acute leukemia given HLA-haploidentical HSCT after ab T-cell and B-cell depletion (2017) (8)
- Insulin resistance in children and adolescents after bone marrow transplantation for malignancies. (2006) (8)
- Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor (2016) (8)
- Hematopoietic stem cell transplantation: 40 years of continuous progress and evolution (2008) (8)
- Absence of IL-12Rβ2 in CD33+CD38+ pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice (2012) (8)
- The Pediatric Acute Leukemia Fusion Oncogene ETO2-GLIS2 Increases Self-Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells-Derived Model (2019) (8)
- Anomalous vascularization in a Wnt medulloblastoma: a case report (2016) (8)
- Infusion of donor-derived peripheral blood leukocytes after transplantation of cord blood progenitor cells can increase the graft-versus-leukaemia effect (1997) (8)
- Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG (2020) (8)
- Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak? (2020) (7)
- Familial haemophagocytic lymphohistiocytosis: survival of a premature twin with immuno-chemotherapy and bone marrow transplantation from an HLA-identical unrelated donor. (2005) (7)
- Interim Results from the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies of Betibeglogene Autotemcel Gene Therapy (LentiGlobin) for the Treatment of Transfusion-Dependent β-Thalassemia (2020) (7)
- Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. (2021) (7)
- Monitoring the Isochromosome i(7)(q10) in the Bone Marrow of Patients With Shwachman Syndrome by Real-time Quantitative PCR (2007) (7)
- Melanotic Neuroectodermal Tumor of Infancy (MNTI) and Pineal Anlage Tumor (PAT) Harbor A Medulloblastoma Signature by DNA Methylation Profiling (2021) (7)
- Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward. (2017) (7)
- Brentuximab Vedotin in Combination with Bendamustine in Relapsed or Refractory Hodgkin Lymphoma: A Retrospective Analysis on 23 Paediatric Patients or Young Adults (2017) (7)
- Clonal Mutational Landscape of Childhood Myelodysplastic Syndromes (2015) (7)
- A Phase I Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Preliminary Results of the ITCC-059 Study (2019) (7)
- Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) (2019) (7)
- T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies (2022) (7)
- Human hepatic stellate cells are liver‐resident antigen‐presenting cells (2011) (7)
- A Multicentric Comparative Analysis of Outcomes of Hla Identical Related Cord Blood and Bone Marrow Transplantation in Patients With Beta-thalassemia Or Sickle Cell Disease (2009) (7)
- Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS (1991) (7)
- Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO* Studies.*Gruppo Italiano Trapianto Midollo Osseo (2010) (7)
- Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia (2022) (7)
- Risk Factors for Outcome after Haploidentical Hematopoietic Stem Cell Transplant in Children with Very High Risk Acute Lymphoblastic Leukemia: Impact of Centre Experience. A Survey on Behalf of the ALWP and PDWP of the EBMT. (2006) (7)
- Monocyte–macrophage polarization and recruitment pathways in the tumour microenvironment of B‐cell acute lymphoblastic leukaemia (2021) (7)
- Rehabilitation of chronic graft versus host disease in children. A clinical series. (2007) (7)
- Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy. AIEOP/FONOP-TMO Group. Italian Association of Paediatric Haemato-Oncology. (1998) (7)
- Transplantation and innate immunity: the lesson of natural killer cells (2009) (7)
- Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantation. (2011) (7)
- Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia ( JMML ) with poor outcome (2011) (7)
- Numb Isoforms Deregulation in Medulloblastoma and Role of p66 Isoform in Cancer and Neural Stem Cells (2018) (7)
- Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica. (1998) (7)
- Downregulation of miR‐326 and its host gene β‐arrestin1 induces pro‐survival activity of E2F1 and promotes medulloblastoma growth (2020) (7)
- Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification (2016) (7)
- Expansion of CD4dimCD8+T cells characterizes macrophage activation syndrome and other secondary HLH. (2022) (7)
- Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants (2021) (7)
- Favorable Outcomes in Pediatric Patients in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia (2020) (7)
- Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP) (2021) (7)
- NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdles. (2020) (7)
- Phase I/II study of brentuximab vedotin in pediatric patients (pts) with relapsed or refractory (RR) Hodgkin lymphoma (HL) or systemic anaplastic large-cell lymphoma (sALCL): Interim phase (ph) I safety data. (2013) (7)
- Familial haemophagocytic lymphohistiocytosis: Survival of a premature twin with immuno‐chemotherapy and bone marrow transplantation from an HLA‐identical unrelated donor (2005) (6)
- COVID-19 – pathogenesis and immunological findings across the clinical manifestation spectrum (2021) (6)
- Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol (2021) (6)
- Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma. (2016) (6)
- Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients. (2009) (6)
- Cord blood transplantation in children with hemoglobinopathies (2015) (6)
- Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts (2021) (6)
- CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study (2022) (6)
- Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study. (2009) (6)
- Long-Term Efficacy and Safety of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia: Results in Patients with up to 6 Years of Follow-up (2020) (6)
- Overcoming Challenges in CAR T-cell Product CGMP Release. (2016) (6)
- 194 Myelodysplastic syndrome or leukemia developing after MDS treated by allogeneic bone marrow transplantation: Outcome of 90 adult patients (1997) (6)
- Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data (2014) (6)
- QuantiFERON‐TB Gold can help clinicians in the diagnosis of haemophagocytic lymphohistiocytosis (2020) (6)
- KIR B haplotype donors confer a reduced risk of relapse after haploidentical transplantation in children with acute lymphoblastic leukemia (2014) (6)
- Upfront azacitidine (AZA) in juvenile myelomonocytic leukemia (JMML): Interim analysis of the prospective AZA-JMML-001 study. (2019) (6)
- Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis (2018) (6)
- HLA Haploidentical Stem Cell Transplantation After Removal of αβ + T Lymphocytes and B Lymphocytes Is an Effective Treatment for Children with Life-Threatening, Non-Malignant Disorders (2012) (6)
- A three‐miRNA‐based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1‐RUNX1T1 acute myeloid leukaemia (2018) (6)
- Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
- Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies.Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019. Erratum in: Front Immunol. 2019 May 31;10:1184. (2019) (6)
- A New Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) for Alemtuzumab Determination: Development, Validation and Application (2007) (6)
- Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells (2021) (6)
- Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell death. (2020) (6)
- Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia (2020) (6)
- Mesenchymal Stem Cells for Treatment of Severe Acute and Extensive Chronic Graft-Versus-Host Disease. (2005) (6)
- Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis. (2017) (6)
- A Phase II Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of the ITCC-059 Study (2020) (6)
- Hematopoietic Stem Cell Transplantation from HLA Identical Sibling Forsickle Cell Disease an International Survey on Behalf of Eurocord-Monacord, EBMT Paediatric Disease Working Party and CIBMTR (2015) (6)
- Blinatumomab use in pediatric patients (pts) with relapsed/refractory B-precursor acute lymphoblastic leukemia (r/r ALL) from an open-label, multicenter, expanded access study. (2017) (6)
- Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation (2016) (6)
- Administration of BPX-501 Cells Following Αβ T and B-Cell-Depleted HLA-Haploidentical HSCT (haplo-HSCT) in Children with Malignant or Non-Malignant Disorders (2018) (6)
- FAK Signaling in Rhabdomyosarcoma (2020) (6)
- Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
- Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (2021) (6)
- Outcome of Infants Younger Than 1 Year with Acute Lymphoblastic Leukemia Treated with the Interfant-06 Protocol; Results from an International Randomised Study (2018) (6)
- Very late relapse in a patient with acute promyelocytic leukemia (APL) rescued with a chemotherapy-free protocol (2017) (6)
- Myelodysplastic syndromes in children (2018) (6)
- SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation (2018) (6)
- Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting. (2009) (6)
- Adoptive Transfer of Herpesvirusspecific Cytotoxic T Lymphocytes in Transplant Recipients. (2000) (6)
- CD19 Redirected CAR NK Cells Are Equally Effective but Less Toxic Than CAR T Cells (2018) (6)
- Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors (2019) (6)
- Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy (2021) (6)
- Results of Unrelated Cord Blood Transplants in Fanconi Anemia. (2004) (6)
- Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors (1996) (6)
- INTERNATIONAL COLLABORATIVE TREATMENT PROTOCOL FOR INFANTS UNDER ONE YEAR WITH ACUTE LYMPHOBLASTIC OR BIPHENOTYPIC LEUKEMIA (2015) (6)
- Delayed Transfer of Immune Cells or the Art of Donor Lymphocyte Infusion (2018) (6)
- Proactive evaluation of clinical risk: a FMECA analysis in pediatric chemotherapy. (2013) (6)
- Alloreactive natural killer cells in targeting high-risk leukaemias (2008) (6)
- Co-Transplantation of HLA-Haploidentical, Bone Marrow Derived Mesenchymal Stem Cells Prevents Graft Failure and Improves Hematological Recovery in T-Cell Depleted Haploidentical Stem Cell Transplantation. (2007) (6)
- A registry of HLA‐typed donors for production of virus‐specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune‐compromised patients (2014) (5)
- Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in Italy. AIEOP/FONOP TMO Group (1998) (5)
- Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (2021) (5)
- Identification of the novel HLA‐A*01:289 allele in an Italian patient (2019) (5)
- Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content (2018) (5)
- Hematopoietic stem cell transplantation : Improving alloreactive Bw 4 donor selection by genotyping codon 86 of KIR 3 DL 1 / S 1 (2016) (5)
- Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation (2005) (5)
- Alternative therapies and the Di Bella affair in pediatrics. A questionnaire submitted to Italian pediatric oncologists and hematologists. (2000) (5)
- Incidence of Hypersensitivity Reactions (HSR) Reactions (HSR) to Peg-Asparaginase (PEG-ASP) in 6136 Patients Treated in the AIEOP-BFM ALL 2009 Study Protocol (2019) (5)
- The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics (2021) (5)
- Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities (2019) (5)
- mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients (2022) (5)
- Efficacy and safety of daratumumab (DARA) in pediatric and young adult patients (pts) with relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL): Results from the phase 2 DELPHINUS study. (2022) (5)
- Human mesenchymal stromal cells primed with paclitaxel, apart from displaying anti-tumor activity, maintain their immune regulatory functions in vitro. (2014) (5)
- Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. (2006) (5)
- HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia (2008) (5)
- Progressive increase in D-dimer levels during extracorporeal membrane oxygenation can predict membrane oxygenator failure in children given hematopoietic stem cell transplantation? (2016) (5)
- How I treat Juvenile Myelomonocytic Leukemia (JMML) (2015) (5)
- Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses (2021) (5)
- Cord blood transplantation for acute leukemia (2020) (5)
- ISOLATION AND EX VIVO EXPANSION OF BONE MARROW-DERIVED PORCINE MESENCHYMAL STROMAL CELLS: POTENTIAL FOR APPLICATION IN AN EXPERIMENTAL MODEL OF SOLID ORGAN TRANSPLANTATION IN LARGE ANIMALS: 1470 (2010) (5)
- JMML Revisited: Role Und Outcome of Hematopoietic Stem Cell Transplantation in Subtypes of Juvenile Myelomonocytic Leukemia (JMML) (2012) (5)
- Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial (2022) (5)
- A phase II clinical study of pomalidomide (CC-4047) monotherapy for children and young adults with recurrent or progressive primary brain tumors. (2019) (5)
- Familial haemophagocytic lymphohistiocytosis treated with allogeneic bone marrow transplantation. (1991) (5)
- Rhabdomyosarcoma with primary osteolytic lesions simulating non-Hodgkin's lymphoma. (1991) (5)
- [The contribution of the Italian Association of paediatric haematology and oncology (AIEOP)]. (2016) (5)
- Impact of treosulfan exposure on early and long-term clinical outcome in pediatric allogeneic HSCT recipients: a prospective multicenter study. (2021) (5)
- Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation (2021) (5)
- Vancomycin-resistant Enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation : clinical and microbiological features (2000) (5)
- Pediatric patients with acute lymphoblastic leukemia treated with blinatumomab in a real‐world setting: Results from the NEUF study (2022) (5)
- Analysis of memory-like Natural Killer cells in Human Cytomegalovirus-infected children undergoing + T-and B-cell depleted HSCT for hematological malignancies (2015) (5)
- Comparison of the outcome of unrelated bone marrow (Bm) Or cord blood (Cb) Transplant in children with acute leukemia (Al) (2000) (5)
- Removal Of Alpha/Beta+ T Cells and Of CD19+ B Cells From The Graft Translates Into Rapid Engraftment, Absence Of Visceral Graft-Versus-Host Disease and Low Transplant-Related Mortality In Children With Acute Leukemia Given HLA-Haploidentical Hematopoietic Stem Cell Transplantation (2013) (5)
- Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen in Patients with Wiskott-Aldrich Syndrome Given Allogeneic Hematopoietic Cell Transplantation — an EBMT Inborn Errors Working Party and Scetide Retrospective Analysis (2018) (4)
- Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies. AIEOP-BMT Group (Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplant Group) (1999) (4)
- Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation (2021) (4)
- Evidence of pediatric sepsis caused by a drug resistant Lactococcus garvieae contaminated platelet concentrate (2022) (4)
- Immunomodulatory properties of porcine, bone marrow-derived multipotent mesenchymal stromal cells and comparison with their human counterpart. (2011) (4)
- NK Cell Reconstitution in Paediatric Leukemic Patients after T-Cell-Depleted HLA-Haploidentical Haematopoietic Stem Cell Transplantation Followed by the Reinfusion of iCasp9-Modified Donor T Cells (2019) (4)
- Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience (2018) (4)
- Whole Genome MBD‐seq reveals different CpG methylation patterns in Azacytidine‐treated Juvenile Myelomonocytic Leukaemia (JMML) patients (2018) (4)
- Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation. (1995) (4)
- Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks (2019) (4)
- Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia (2022) (4)
- Structural variation in SBDS gene, with loss of exon 3, in two Shwachman-Diamond patients. (2016) (4)
- Early intensification followed by allo-BMT or auto-BMT or a second intensification in adult ALL: a randomized multicenter study. (1992) (4)
- Superior Event-Free Survival with Blinatumomab Versus Chemotherapy in Children with High-Risk First Relapse of B-Cell Precursor Acute Lymphoblastic Leukemia: A Randomized, Controlled Phase 3 Trial (2020) (4)
- DHH-RHEBL 1 fusion transcript : a novel recurrent feature in the new landscape of pediatric CBFA 2 T 3-GLIS 2-positive acute myeloid leukemia (2013) (4)
- Hemoperfusion with CytoSorb to Manage Multiorgan Dysfunction in the Spectrum of Hemophagocytic Lymphohistiocytosis Syndrome in Critically Ill Children (2021) (4)
- Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high‐dose imatinib (2018) (4)
- Recombinant human erythropoietin may correct erythropoietin‐deficient hyporegenerative anaemia in children given cardiac transplantation (1994) (4)
- Impact of Somatic Mutations on the Outcome of Children and Adolescents with Therapy-Related Myelodysplastic Syndrome (2016) (4)
- Interaction of Human Mesenchymal Stem Cells with Alloantigen-Induced T Lymphocyte Activation Favors the Differentiation of CD4+ T Cell Subsets Expressing CD25 and/or CTLA4 Molecules. (2004) (4)
- High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome. (2005) (4)
- Higher Death Rates in the Italian COVID-19 Outbreak: A Comparative Modelling Analysis of 8,342 Italy and 44,672 China Cases (2020) (4)
- CD19 expression in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia pre‐ and post‐treatment with blinatumomab (2021) (4)
- Immune Cell Phenotype and Function After Treatment With Blinatumomab For Childhood Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) (2013) (4)
- Administration of BPX-501 Cells Following Aβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias (2018) (4)
- β-Arrestin1/miR-326 Transcription Unit Is Epigenetically Regulated in Neural Stem Cells Where It Controls Stemness and Growth Arrest (2017) (4)
- Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP) (2018) (4)
- CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome. (2022) (4)
- The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia (2021) (4)
- B-cell depleting immunotherapies: therapeutic opportunities and toxicities (2019) (4)
- Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy. (2005) (4)
- Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy (2018) (4)
- Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome. (2017) (4)
- Characterization of the novel HLA‐DQA1*01:49 allele by sequencing‐based typing (2019) (4)
- Characterization of KIR + NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C (2022) (4)
- Blinatumomab in Children with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R-ALL): Final Results of 110 Patients Treated in an Expanded Access Study (RIALTO) (2020) (4)
- Transplantation Induces Profound Changes in the Transcriptional Asset of Hematopoietic Stem Cells: Identification of Specific Signatures Using Machine Learning Techniques (2020) (4)
- Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPG (2018) (4)
- Developing cell therapies as drug products (2020) (4)
- Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience (2022) (4)
- Is there a role for cytokine-induced killer cells in cancer immunotherapy? (2012) (4)
- Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse? (2002) (4)
- Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas (2020) (4)
- CD56, HLA‐DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3‐GLIS2 fusion transcript (2021) (4)
- Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose (2022) (4)
- FGFR1 is a potential therapeutic target in neuroblastoma (2022) (4)
- Safety of Autologous Hematopoietic Stem Cell Transplantation with Gene Addition Therapy for Transfusion-Dependent β-Thalassemia, Sickle Cell Disease, and Cerebral Adrenoleukodystrophy (2020) (4)
- Consensus of the Italian Primary Immunodeficiency Network on Transition Management from Pediatric to Adult Care in Patients Affected with Childhood Onset Inborn Errors of Immunity. (2020) (4)
- FRI0540 A NOVEL AUTOINFLAMMATORY DISEASE CHARACTERIZED BY NEONATAL-ONSET CYTOPENIA WITH AUTOINFLAMMATION, RASH, AND HEMOPHAGOCYTOSIS (NOCARH) DUE TO ABERRANT CDC42 FUNCTION (2019) (4)
- Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia. (2009) (4)
- Miniaturized and High-Throughput Assays for Analysis of T-Cell Immunity Specific for Opportunistic Pathogens and HIV (2014) (4)
- AT-cell epitope encoded by a subset of HLA-DPB 1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation (2004) (3)
- The Genomic Landscape of Childhood and Adult Acute Erythroid Leukemia (2016) (3)
- Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies (1999) (3)
- Bone marrow transplantation from unrelated donors : the Italian experience (1993) (3)
- High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: Rialto an Open-Label, Multicenter, Expanded Access Study (2018) (3)
- Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model‐based approach (2021) (3)
- Lymphocyte proliferation specific for recall, CMV and HIV antigens in miniaturized and automated format. (2012) (3)
- Antibiotic prophylaxis and management of infections in pediatric hematopoietic stem cell transplantation: a survey from the Stem Cell Transplant and the Infectious Disease Working Groups of the AIEOP network (2022) (3)
- Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia (2017) (3)
- Acute Lymphoblastic Leukemia in Children and Adolescents (2018) (3)
- Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision model (2018) (3)
- Identification of a Genetic Variation in ERAP 1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL 1125 p-Mediated Immunoevasion Graphical (2017) (3)
- 22: Outcomes after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia: A Eurocord-Netcord Survey (2006) (3)
- Busulfan as part of conditioning regimen for bone marrow transplantation in children. (1991) (3)
- Looking for pathways related to COVID-19 phenotypes: Confirmation of pathogenic mechanisms by SARS-CoV-2 - Host interactome (2020) (3)
- Long-term results of the 'Prospective study of the diagnosis and treatment of myelodysplastic syndromes in childhood (EWOG-MDS98)' (2015) (3)
- Microarray expression studies on bone marrow of patients with Shwachman-Diamond syndrome in relation to deletion of the long arm of chromosome 20, other chromosome anomalies or normal karyotype (2020) (3)
- Do Not Exhibit Telomere Maintenance Mechanisms Culture In vitro Not Undergo Transformation after Long-term Derived Mesenchymal Stem Cells Do − Human Bone Marrow (2007) (3)
- Characterization of the novel HLA‐DPA1*01:03:19 allele by sequencing‐based typing (2020) (3)
- T-cell depletion to prevent GVHD after unrelated-donor marrow transplantation (2005) (3)
- Emapalumab in Primary Hemophagocytic Lymphohistiocytosis. Reply. (2020) (3)
- Outcome of Children with All Given HSCT from Unrelated Volunteers Has Significantly Improved over Time and Now Is Comparable to That of Children Transplanted from an HLA-Identical Sibling. (2004) (3)
- The EURE‐CART project as a prototype model for CAR T‐cell immunotherapy in Europe (2018) (3)
- Anti-Leukemia Activity of Alloreactive NK Cells in Haploidentical HSCT in Pediatric Patients: Re-Defining the Role of Activating and Inhibitory KIR (2008) (3)
- Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome (2016) (3)
- Human cytomegalovirus immediate early-mRNAemia vs pp65-antigenemia for guiding pre- emptive therapy in children and young adults given hematopoietic stem cell transplantation: a prospective, randomized, open-label trial Short title: HCMV IEmRNA vs antigenemia for monitoring HSCT recipients (2003) (3)
- PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP) (2014) (3)
- Mother Donors Improve Outcomes after HLA Haploidentical Hematopoietic Transplantation: A Retrospective Study By the Cell Therapy and Immunobiology Working Party of the EBMT (2016) (3)
- Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies (2020) (3)
- Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation or Chemotherapy--Results from the Italian Therapeutic Use Protocol (2015) (3)
- Clonal Evolution and Lack of BCR-ABL1 Mutations in Pediatric Ph+ ALL Patients Resistant/Refractory to Imatinib Treatment (2015) (3)
- Programming a hematopoietic stem cell donor: the evolution of a project over time. (2006) (3)
- Bone marrow failure may be caused by chromosome anomalies exerting effects on RUNX1T1 gene (2018) (3)
- Administration of BPX-501 Cells Following Αβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias (AL) (2019) (3)
- Clinical Outcome after Adoptive Infusion of BPX-501 Cells (donor T cells transduced with iC9 suicide gene) in Children Given Alpha/Beta T-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT): Preliminary Results of a Phase I-II Trial (2015) (3)
- Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma (2022) (3)
- P360: EFFICACY AND SAFETY OF DARATUMUMAB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA: RESULTS FROM PHASE 2 DELPHINUS STUDY (2022) (3)
- Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia (2022) (3)
- Bianca: Phase II, single-arm, global trial to determine efficacy and safety of tisagenlecleucel in pediatric/young adult (YA) patients (Pts) with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL). (2020) (3)
- Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors (2022) (3)
- Negative Depletion of B Cells and T Cells Expressing the αβ Chain of the T-Cell Receptor (TCR) for Haploidentical Stem Cell Transplantation (2012) (3)
- Donor/Recipient Mixed Chimerism Does Not Predict Graft Failure in Children with Beta-Thalassemia Given Allogeneic Cord Blood Transplantation from An HLA-Identical Related Donor (2008) (3)
- Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD) (2018) (3)
- 3232 Synergistic cytotoxic effects of bortezomib and ck2 inhibitor cx-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the proapoptotic NF-κb (2015) (3)
- Outcome of Early T-Cell Precursor Acute Lymphoblastic Leukemia in AIEOP Patients Treated with the AIEOP-BFM ALL 2000 Study (2014) (3)
- Transplantation of Ex Vivo Expanded Cord Blood Progenitor Cells: First Experience in Two Children Affected by Hemoglobinopathies. (2005) (3)
- Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study. (2022) (3)
- Monosomy 7 and Deletion 7q in Childhood AML. A Collaborative Study of 20 Study Groups. (2004) (3)
- 199 PHARMACODYNAMIC, PHARMACOKINETIC AND PLASMA MONITORING OF BUSULFAN IN PEDIATRIC PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. (1997) (3)
- Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation (2017) (3)
- Second bone marrow transplant for children who relapsed or rejected their first graft: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). (1996) (3)
- Unrelated Donor Bone Marrow Transplantation for Class I-II Thalassemia Pediatric Patients. (2005) (3)
- MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression (2022) (3)
- Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy (2022) (3)
- Cord blood: a new source of hematopoietic stem cells (2009) (3)
- Analysis of rare driving events in pediatric acute myeloid leukemia (2022) (3)
- Systemic granulomatosis after surgical injection of silicone oil for retinal detachment in a child affected by Fisher-Evans syndrome. (2015) (3)
- Treatment of childhood acute lymphoblastic leukemia in first remission with allogeneic bone marrow transplantation or with intensive chemotherapy: a cooperative Italian study. The AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo), (1996) (3)
- ERAAP modulation: A possible novel strategy for cancer immunotherapy? (2012) (3)
- Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). (2002) (3)
- Identification of the novel HLA‐DPB1*1149:01 (2021) (2)
- Acute Myeloid Leukemia (AML) in a 3D Bone Marrow Niche Showed High Performance for in Vitro and In Vivo Drug Screenings (2019) (2)
- Allogeneic bone marrow transplantation in children with ANL: Italian experience. AIEOP Group and the GITMO. (1991) (2)
- The strange case of the lost NRAS mutation in a child with juvenile myelomonocytic leukemia (2012) (2)
- Academic, Phase I/II Trial on T Cells Expressing a Second Generation, CD19-Specific Chimeric Antigen Receptor (CAR) and Inducible Caspase 9 Safety Switch for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) and B-Cell Non-Hodgkin Lymphoma (B-NHL) in Children (2019) (2)
- Phenotypical and Functional Characterization of in Vitro Expanded Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Crohn’s Disease (2008) (2)
- Quantitative ultrasound detects bone changes following bone marrow transplantation in pediatric subjects with hematological diseases: a longitudinal study. (2010) (2)
- Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors (2006) (2)
- Chronic graft-versus-host disease and non-melanoma skin cancer in children: report of two cases. (2008) (2)
- Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia. (2006) (2)
- High Dose Methotrexate (HD MTX at 2 gr/sqm x 4) Associated to Extended Intrathecal (IT) Chemotherapy Is Effective for Prevention of Central Nervous System (CNS) Relapse in Childhood ALL Treated with BFM Systemic Therapy. (2005) (2)
- In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study (2013) (2)
- T-Cell Depleted HLA-Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (haplo-HSCT) Followed By Donor Lymphocyte Infusion with T Cells Transduced with the Inducible Caspase 9 (iC9) Suicide Gene in Children with Hematological Malignancies (2016) (2)
- Superior Overall Survival with Blinatumomab Versus Chemotherapy As Pre-Transplant Consolidation Treatment in Children with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL): Longer Follow-up (FU) of a Phase 3 Randomized Controlled Trial (RCT) (2021) (2)
- Potential Impact of Treatment with Inotuzumab Ozogamicin on Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (2021) (2)
- Cord blood transplantation in childhood. (2000) (2)
- Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (2018) (2)
- Non-Radiolabelled PCR Consensus Primers and Automatic Sequencing Enable Rapid Identification of Tumor-Specific VH CDR3 in Aggressive B-Cell Malignancies (2003) (2)
- Unrelated Cord Blood Transplantation for Children with Juvenile Myelomonocytic Leukemia. (2007) (2)
- Hematopoietic Stem Cell Transplantation (HSCT) after a Myeloablative Conditioning Regimen in Children with Refractory Cytopenia (RC): Results of a Retrospective Analysis from the EWOG-MDS Group. (2007) (2)
- Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis (2022) (2)
- Allogeneic transplantation of haematopoietic progenitors for myelodysplastic syndromes and myeloproliferative disorders. (1998) (2)
- Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients. (2009) (2)
- features Imatinib for refractory chronic graft-versus-host disease with fibrotic (2011) (2)
- Cyclosporine a as a possible cause of upbeating nystagmus (1997) (2)
- Clinical Outcome after Adoptive Infusion of BPX-501 Cells (donor T cells transduced with iC9 suicide gene) in Children with Thalassemia Major (TM) Given Alfa/Beta T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation (HSCT) (2016) (2)
- Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies (2019) (2)
- Quantitative ultrasound detects bone changes following bone marrow transplantation in pediatric subjects with hematological diseases: A longitudinal study (2010) (2)
- Preservation of Antigen-Specific Functions of αβ T Cells and B Cells Removed from Hematopoietic Stem Cell Transplants Suggests Their Use As an Alternative Cell Source for Advanced Manipulation and Adoptive Immunotherapy (2017) (2)
- Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adults with Chronic Granulomatous Disease (CGD): A Study of the Inborn Errors Working Party (IEWP) of the EBMT (2018) (2)
- Outcome Of Unrelated Umbilical Cord Blood Transplantation For Children With Osteopetrosis: An Eurocord and Inborn Errors Working Party (IEWP)-EBMT Study (2013) (2)
- Mesenchymal stem cells for acute graft-versus-host disease – Authors' reply (2008) (2)
- Tolerance: pregnancy matters. (2009) (2)
- Sharing and reusing therapeutic knowledge for managing leukemic children (1993) (2)
- Human leucocyte antigen diversity: A biological gift to escape infections, no longer a barrier for haploidentical Hemopoietic Stem Cell Transplantation (2019) (2)
- Single-agent dose-finding cohort of a phase 1/2 study of lenvatinib (LEN) in children and adolescents with refractory or relapsed solid tumors. (2017) (2)
- QUALITY OF LIFE/AFTERCARE (2012) (2)
- Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT) (2020) (2)
- Long-Term Outcome of Children with Acute Leukemia (AL) Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) (2019) (2)
- Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia: Outcomes from the Phase 1/2 Northstar and Phase 3 Northstar-2 Studies (2019) (2)
- Successful of Chemo-Free Treatment with Dasatinib and Blinatumomab in a Pediatric EBF1-PDGFRβ Positive Acute Lymphoblastic Leukemia (2018) (2)
- Administration of BPX-501 Following α-T and B-Cell Depleted Haplo-HSCT in Children with Transfusion-Dependent Thalassemia (2018) (2)
- Repurposing anthelmintic agents to eradicate resistant leukemia (2020) (2)
- Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major (2022) (2)
- Treatment Intensification of Traditional BFM Therapy with 3 Chemotherapy Blocks and Double Delayed Intensification (Protocol II) Improves Outcome in Infants with High Risk (HR) Acute Lymphoblastic Leukemia (ALL): Results of Two Consecutive AIEOP Studies. (2005) (2)
- Use of Ruxolitinib to control Graft-versus-Host Like Disease in Omenn Syndrome and successfully bridging to HSCT. (2021) (2)
- Donor Leukocyte Infusion after Stem Cell Transplantation in Patients with Juvenile Myelomonocytic Leukemia. (2004) (2)
- Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Transfusion-Dependent β-Thalassemia Treated at the Bambino Gesù Children's Hospital, Rome, Italy (2019) (2)
- Unpurged autologous bone marrow transplantation for neuroblastoma: the AIEOP-BMT group experience. (1991) (2)
- Mother donors improve outcomes after HLA haploidentical transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the EBMT. (2022) (2)
- Steroid-Refractory Acute Gvhd in Children: Retrospective Analysis of the AIEOP HSCT Registry (2018) (2)
- Invariant Natural Killer T-cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and associates with the remission state (2011) (2)
- Allogeneic Stem Cell Transplantation for Children with Advanced Primary MDS: Results from the EWOG-MDS Study Group Employing a Pre-Transplant Preparative Regimen with Busulfan, Cyclophosphamide and Melphalan. (2004) (2)
- Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study (2017) (2)
- Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial (2020) (2)
- Long‐term results of AIEOP‐8805 protocol for acute B‐cell lymphoblastic leukemia of childhood (2011) (2)
- Pubertal development after bone marrow transplantation in adolescents. (1991) (2)
- Unrelated Cord Blood Transplantation For Infant Acute Leukemia Diagnosed Within 1 Year Of Age: Outcomes and Risk Factor Analysis On Behalf Of Eurocord and PDWP-EBMT (2013) (2)
- NUP98 Fusion Proteins Are Recurrent Aberrancies in Childhood Acute Myeloid Leukemia: A Report from the AIEOP AML-2001-02 Study Group (2014) (2)
- The role of total body irradiation (TBI). The Italian Association of Pediatric Hematology Oncology (AIEOP) BMT Study Group. (1996) (2)
- Children with Acute Leukemia Given Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Compatible Sibling, or an Unrelated Donor (UD) or an HLA-Haploidentical Relative after Alpha/Beta T-Cell Depletion Have a Comparable Outcome (2015) (2)
- In-Vivo Expansion of T Regulatory Cells by Rapamycin in a Calcineurin-Inhibitor Free GVHD Prophylaxis in Unmanipulated Haploidentical Stem Cell Transplantation (SCT) (2011) (2)
- A new baby in the c-Myc-directed transcriptional machinery: Che-1/AATF (2018) (2)
- Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 336 Children between 2005 and 2016 (2017) (2)
- Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL. (2017) (2)
- Direct Involvement of Cranial Nerve V at Diagnosis in Patients With Diffuse Intrinsic Pontine Glioma: A Potential Magnetic Resonance Predictor of Short-Term Survival (2019) (2)
- Phase II Study of Midostaurin + Chemotherapy in Pediatric Patients with Untreated, Newly Diagnosed, FLT3-Mutated Acute Myeloid Leukemia (AML) (2019) (2)
- Autologous bone marrow transplantation for extramedullary relapse in childhood leukemia. The AIEOP Group and the FONOP. Italian Association of Pediatric Hemato/Oncology. (1996) (2)
- Identification of the novel HLA‐B allele, HLA‐B*44:532 by next‐generation sequencing (2021) (2)
- Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia-Reply. (2021) (2)
- Ruxolitinib in Pediatric Patients with Treatment-Naïve or Steroid-Refractory Acute Graft-Versus-Host Disease: Primary Findings from the Phase I/II REACH4 Study (2022) (2)
- Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients — a 25‐year Italian experience (2021) (2)
- Vernal keratoconjunctivitis in twins: case report and literature review (2021) (2)
- Identification of a new HLA‐B*44 allele, HLA‐B*44:02:68, by next generation sequencing (2021) (2)
- The novel HLA‐DRB3*02:02:11 allele identified in an Italian individual (2018) (2)
- Characterization of the novel HLA‐DPA1*02:15 allele by sequencing‐based typing (2019) (2)
- Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia (2022) (2)
- ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature (2022) (2)
- Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML (2021) (2)
- Glucocorticoids inhibit human hematopoietic stem cell differentiation toward a common ILC precursor. (2021) (2)
- Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients (2021) (2)
- Case Report: Trichosporon japonicum Fungemia in a Pediatric Patient With Refractory Acute B Cell Lymphoblastic Leukemia (2022) (2)
- Ethics in clinical autopsy (2020) (2)
- Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency (2017) (2)
- The immune response as a double‐edged sword: The lesson learnt during the COVID‐19 pandemic (2022) (2)
- Risk Factors Analyses for Outcomes after Unrelated Cord Blood Transplantation for Children with Myelodysplastic Syndromes. An Analysis on Behalf of EWOG-MDS and Eurocord Groups. (2007) (1)
- Allogenic stem cell transplantation following non-myeloablative conditioning regimens as adoptive immunotherapy in patients with hematological malignancies. (2002) (1)
- Signaling Crosstalks Drive Generation and Regeneration of the Thymus (2022) (1)
- Pre-transplant CYA. Preliminary results of a randomized study in pediatric recipients of unrelated-donor BMT. (1999) (1)
- COVID-19 Disease - Temporal Analyses of Complete Blood Count Parameters Over Course of Illness, and Relationship to Patient Demographics and Management Outcomes in Survivors and Non-Survivors: A Longitudinal Descriptive Cohort Study (2020) (1)
- Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: disorders due to secondary impairment of RUNX1 and MPL genes (2012) (1)
- Imatinib as Salvage Therapy for Patients with Refractory cGVHD: the Interim Analysis of the Prospective GITMO* Multicenter Study*Gruppo Italiano Trapianto Di Midollo Osseo. (2009) (1)
- TCRαβ/CD19 depleted hematopoietic stem cell transplantation from haploidentical donors: dissecting the GvL/GvHD conundrum (2020) (1)
- Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient (2022) (1)
- Impact of Minimal Residual Disease at Unrelated Cord Blood Transplantation In Children with Acute Lymphoblastic Leukemia In Remission: a Study on Behalf of Eurocord-EBMT and EBMT-PDWP (2010) (1)
- S140 RESULTS FROM THE PHASE 3 NORTHSTAR-3 STUDY EVALUATING LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSAEMIA AND A β0 OR IVS-I-110 MUTATION AT BOTH ALLELES OF THE HBB GENE (2019) (1)
- Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric Population (2022) (1)
- Hematopoietic Stem Cell Transplantation in 65 Patients with Leukocyte Adhesion Deficiency Type I and Type III — A Retrospective Multi-Center Study (2017) (1)
- qualitative pp65-antigenemia receiving haematopoietic stem cell transplantation as compared to reduces the number of pre-emptively treated children and young adults Use of a DNAemia cut-off for monitoring human cytomegalovirus infection (2013) (1)
- Growth in pubertal children after bone marrow transplantation. (1991) (1)
- Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients (2021) (1)
- Case Report: Precision COVID-19 Immunization Strategy to Overcome Individual Fragility: A Case of Generalized Lipodystrophy Type 4 (2022) (1)
- Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry (2022) (1)
- Emergence of anti-tumor cytolytic T cells is associated with maintenance of hematological remission in children with acute myeloid leukemia (2006) (1)
- Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma (2022) (1)
- Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene (2020) (1)
- Immunosuppressive therapy with anti-thymocyte globin and cyclosporine A in patients with refractory cytopenia in childhood (2011) (1)
- A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumors. (2020) (1)
- The ETO2-GLIS2 Fusion Oncogene Alters Early Human Hematopoiesis in an Induced Pluripotent Stem Cells-Derived Model of Pediatric Acute Megakaryoblastic Leukemia (2017) (1)
- Local control in metastatic neuroblastoma in children over 1 year of age (2015) (1)
- Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent (2014) (1)
- NF1 Tumor Suppressor Gene Inactivation in Juvenile Myelomonocytic Leukemia: New Genetic Evidence and Consequences for Diagnostic Work-up (2020) (1)
- Indoleamine 2,3-dioxygenase-1 (IDO1) expression by childhood acute myeloid leukemias inhibits T-cell production of IFN-γ and confers an unfavorable prognosis (2013) (1)
- Working Parties (1992) (1)
- Detection of CALM-AF10 Fusion Transcript Does Not Predict A Poor Prognosis in Children with T-Lineage Acute Lymphoblastic Leukemia Treated with AIEOP ALL 2000 Protocol and Subsequent Modified 2000 Study (R-2006). (2009) (1)
- Co-Transplantation of Haploidentical Bone Marrow Derived Mesenchymal Stem Cells Overcomes Graft Dysfunction and Improves Hematological and Lymphocyte Recovery in Haploidentical Stem Cell Transplantation. (2006) (1)
- Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T‐acute lymphoblastic leukemia and T‐lymphoblastic lymphoma (study T2008‐002 NECTAR) (2022) (1)
- Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity. (2022) (1)
- Efficacy, Safety, and Pharmacokinetics (PK) of Azacitidine (AZA) in Children and Young Adults with Acute Myeloid Leukemia (AML) in the Phase 2 AZA-AML-004 Trial (2020) (1)
- Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen for Patients with Wiskott-Aldrich Syndrome – an EBMT Inborn Errors Working Party and Scetide Study (2019) (1)
- Application of mathematical logic for immunophenotyping of B-Cell precursor acute lymphoblastic leukemia (BCP-ALL) (2019) (1)
- 453: Enhancer of Zeste Homolog 2 (EZH2) modulation in either embryonal or PAX3-FOXO1 alveolar rhabdomyosarcoma shows different anti-tumoral effects (2014) (1)
- NUP98-KDM5A Fusion Gene Is Not Exclusive to Acute Megakaryoblastic Leukemia and Is an Independent Predictor of Poor Prognosis (2017) (1)
- The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study. (2021) (1)
- HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy (2019) (1)
- Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants (2022) (1)
- Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia (2022) (1)
- Clofarabine and Treosulfan as conditioning for matched related and unrelated HSCT: results from the phase II trial "Clo3o". (2019) (1)
- Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders (2019) (1)
- Reduced-Intensity Allogeneic Bone Marrow Transplantation (2006) (1)
- CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. (2016) (1)
- An ontology-based framework for guideline-driven medical practice. (1997) (1)
- Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Severe Sickle Cell Disease (2022) (1)
- Characterization of Allogeneic T Cells Expressing Inducible Caspase-9 Following Adoptive Transfer in Children Receiving an HLA-Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Myeloid Malignancies (2018) (1)
- Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system (2022) (1)
- Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency. (1990) (1)
- Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after αβ-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network (2017) (1)
- MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression (2022) (1)
- Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study (2015) (1)
- Transplantation of T-Cell Depleted Peripheral Blood Haematopoietic Stem Cells from an HLA-Disparate Family Donor for Children with Hematological Malignancies. (2007) (1)
- Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia. (2022) (1)
- Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: disorders due to secondary impairment of RUNX1 and MPL genes (2012) (1)
- Risk Factors Analysis of Outcomes of Related Cord Blood Transplantation in Children with Hematological Malignancies. (2006) (1)
- Asplenia and spleen hypofunction (2022) (1)
- Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters (2022) (1)
- Activin A, a Potential Key Factor of the Malignant Bone Marrow Niche, Enhances B-Cell Precursor-Acute Lymphoblastic Leukemic Cell Migratory and Invasive Properties (2018) (1)
- Genomic Landscape of Acute Erythroid Leukemia (2016) (1)
- Administration of BPX-501 Cells Following Αβ- T and B-Cell-Depleted HLA-Haploidentical HSCT in Children with Fanconi Anemia (2018) (1)
- OC-0541: Long-term results of the AIEOP MH-89 protocol for pediatric Hodgkin lymphoma (2016) (1)
- Microrna-150 Regulates STAT5b Levels in Juvenile Myelomonocytic Leukemia (JMML) (2015) (1)
- Review Article Strategies to harness immunity against infectious patho- gens after haploidentical stem cell transplantation (2011) (1)
- Alpha/Beta T-Cell and B-Cell Depletion HLA-Haploidentical Hematopoietic Stem Cell Transplantation Is an Effective Treatment for Children/Young Adults with Acute Leukemia (2018) (1)
- O.2.7 Kinetics of Epstein–Barr virus DNA load in different blood compartments of pediatric recipients of T-cell depleted HLA-haploidentical stem cell transplantation (2009) (1)
- Improvement in Health-Related Quality of Life Following Treatment with Betibeglogene Autotemcel in Patients with Transfusion-Dependent β-Thalassemia Enrolled in Phase 3 Studies (2021) (1)
- A New Promising Third Generation CAR-CD30 T-Cell Therapy for CD30+ Lymphoma (2019) (1)
- A Potent Thymic Function Is Associated with a Low Risk of Relapse In Leukemia Patients Treated with Haploidentical Stem Cell Transplantation (2010) (1)
- Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients (Pts) with Glucocorticoid-Refractory Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study (2021) (1)
- Correction to: HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy (2019) (1)
- ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas (2013) (1)
- Unrelated donor marrow transplantation for genetic diseases (1997) (1)
- Comparison of Outcomes in Patients with Cerebral Adrenoleukodystrophy (CALD) Receiving Elivaldogene Autotemcel (eli-cel; Lenti-D) Gene Therapy in Clinical Trials Versus Those Receiving Allogeneic Hematopoietic Stem Cell Transplant in a Contemporaneous Comparator Study (2022) (1)
- Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group (2022) (1)
- Acute abdomen after allogenic hematopoietic stem cell transplantation (2011) (1)
- T and NK cells: two sides of tumor immunoevasion (2013) (1)
- Dna Methylation Is Linked to a Specific Cell-Adhesion Program in Relapsed Pediatric t(8;21)(q22;q22)RUNX1-RUNX1T1 Patients (2016) (1)
- Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL (2022) (1)
- Use of recombinant human G(M)-CSF in children: Conclusions of a European panel (1998) (1)
- Prognostic Relevance of Recurrent Genetic Aberrations in Pediatric Acute Megakaryoblastic Leukemia (2015) (1)
- Role of Allogeneic Hematopoietic Stem Cell Transplantation in t(4;11) Positive Acute Lymphoblastic Leukemia (ALL): A Retrospective Multicenter Study of the Italian Association of Pediatric Hematology and Oncology (AIEOP) (2014) (1)
- Treatment Duration, Symptom Resolution, and Survival in Defibrotide-Treated Patients with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation: Analysis of a Multinational, Prospective, Observational Registry Study (2020) (1)
- Indoleamine 2,3-Dioxygenase-1 (IDO1) Is Expressed by a Subset of Childhood Acute Myeloid Leukemias and Restrains IFN-γ Production by T Cells (2012) (1)
- Post-Transplant Outcomes of Children with Primary Hemophagocytic Lymphohistiocytosis Given Emapalumab to Control Disease (2019) (1)
- HGG-46. Inter and Intra-tumor Heterogeneity of Pediatric-type Diffuse High-Grade Glioma Revealed by High-Dimensional Single-Cell Proteomics (2022) (1)
- Sustained remission of immune-mediated red cell aplasia in a child after intravenous administration of gamma globulin. (1994) (1)
- Comparison Between Related T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation (TCD-Haplo) and Umbilical Cord Blood Transplantation (UCBT) in Pediatric Patients with Acute Leukemia, a Eurocord, PDWP-EBMT Study (2014) (1)
- Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40) (2015) (1)
- Long-Term Outcome of Children with Acute Myeloid Leukemia in First Remission Given Allogeneic HSCT from a Matched Family Donor After a Conditioning Regimen Comprising Busulfan, Cyclophosphamide and Melphalan. (2009) (1)
- Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion (2021) (1)
- FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) (2022) (1)
- NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation (2022) (1)
- Hypodiploidy in Childhood Acute Myeloid Leukemia: A Retrospective Cohort Study within the International Berlin-Frankfurt-Münster Study Group (2018) (1)
- Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses (2019) (1)
- The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies (2021) (1)
- EFFECT OF ACTIVE AND PASSIVE SMOKING ON VASCULAR REACTIVITY IN MOTHERS AND INFANTS (1987) (1)
- in haploidentical hematopoietic stem-cell transplantation failure accelerates lymphocyte recovery and may reduce the risk of graft expanded mesenchymal stem cells - Cotransplantation of ex vivo (2011) (1)
- Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B‐cell acute lymphoblastic leukemia (2023) (1)
- An Early Biomarker Algorithm Predicts Lethal Graft-Vs-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation (2017) (1)
- Genomic subtyping and therapeutic targeting of acute erythroleukemia (2019) (1)
- Rhob Overexpression Boosts Relapse of t(8;21) RUNX1-RUNX1T1 Rearranged Acute Myeloid Leukemia. (2017) (1)
- Restoring Iron Homeostasis in Pts Who Achieved Transfusion Independence after Treatment with Betibeglogene Autotemcel Gene Therapy: Results from up to 7 Years of Follow-up (2021) (1)
- Outcomes after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia. An Eurocord-Netcord Survey. (2005) (1)
- MB-34CIRCULATING microRNAs IN GROUP 4 MEDULLOBLASTOMA PATIENTS (2016) (1)
- Prognostic value of donor cytotoxic T-lymphocyte precursor frequencies for acute graft-versus-host disease in hematopoietic stem cell transplantation from HLA-matched siblings: a single center experience in a cohort of 92 patients. (2006) (1)
- C029 HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia (2009) (1)
- Encoraging Results after Alternative Donor Transplantation for Myelodysplastic Syndrome. (2008) (1)
- Unrelated Donor Transplants for Severe Aplastic Anemia: A Report from the EBMT SAA Working Party. (2007) (1)
- Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (2021) (1)
- Reduced intensity conditioning for children with refractory cytopenia of childhood : results of the EWOG-MDS study SCT RX RIC 06 (2014) (1)
- PS1226 DEVELOPMENT OF INNOVATIVE PRECLINICAL IN VITRO AND IN VIVO TOOLS FOR AN EFFECTIVE THERAPEUTIC STRATEGY IN PEDIATRIC ACUTE MYELOID LEUKEMIA (2019) (1)
- The RNA editing enzymes ADARs: mechanism of action and human disease (2014) (1)
- Proceedings of the 9th International Symposium on MDS and SAA in Childhood (2021) (1)
- Impact of Minimal Residual Disease (MRD) Assessed before Transplantation on the Outcome of Children with Acute Myeloid Leukemia Given an Allograft: A Retrospective Study By the I-BFM Study Group (2020) (1)
- FLT3-ITD As a Target for Minimal Residual Disease Monitoring in Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (2014) (1)
- Reconstitution of repertoire of natural killer cell receptors after transplantation: just a question of time? (2010) (1)
- Enhancer of Zeste Homolog 2 (EZH2) expression and activation in in vivo and in vitro non-alcoholic fatty liver disease (NAFLD) (2014) (1)
- Abstract B35: Liaison between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in fusion-negative rhabdomyosarcoma (2020) (1)
- Waning of Serum Antibodies, But Increase of Protective B-Cell Memory Nine Months After BNT162b2 Vaccination (2021) (1)
- TEL/AML1 Rearrangement Is Rare in Children with Acute Lymphoblastic Leukemia (ALL) and Down Syndrome (DS). Presenting Features and Treatment Outcome in the Experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). (2007) (1)
- This information is current as Macrophages Human NK Cells , Monocytes , and M 2 Imatinib and Nilotinib Off-Target Effects on (2017) (1)
- Gamma-immunoglobulins and adeno-splenomegaly in chronic lymphocytic leukemia (CLL). (1985) (1)
- Intermittent Imatinib Mesylate in Children with Chronic Myeloid Leukemia: Results and Outcome (2018) (1)
- Outcome of (Novel) Subgroups in 1257 Pediatric Patients with KMT2A-Rearranged Acute Myeloid Leukemia (AML) and the Significance of Minimal Residual Disease (MRD) Status: A Retrospective Study By the I-BFM-SG (2020) (1)
- Phenotypical and Functional Characterization of Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Expanded in the Presence of Platelet Lysate and Comparison with Their Bone Marrow-Derived Counterpart (2008) (1)
- T- and B-Cell Neogenesis Recovers Efficiently in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Followed By Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (BPX-501 cells) (2018) (1)
- Recovery Of Gamma/Delta+ T Cells After Transplantation With Alpha-Beta+/CD19+ Lymphocyte Depleted Hematopoietic Stem Cells From HLA-Haploidentical Donors (2013) (1)
- Stem cell transplantation for therapy-related myelodysplastic syndrome following treatment for childhood acute lymphoblastic leukaemia (2011) (0)
- treatment of children with acute myeloid leukemia Results of the AIEOP AML 2002/01 multicenter prospective trial for the (2013) (0)
- Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen–Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency Biology of Blood and Marrow Transplantation (2016) (0)
- Second-Line Treatment for Steroid-Refractory Graft-Versus-Host Disease with Mesenchymal Stromal Cells. A Conceptual Disease Model (2017) (0)
- Open basic research question : why do blast cells of pediatric patients with ALL seem to be more susceptible to NK cell lysis than leukemia cells of adult ALL ? (2013) (0)
- MYELOID NEOPLASIA Recurrent abnormalities can be used for risk group strati fi cation in pediatric AMKL: a retrospective intergroup study (2016) (0)
- Mutations of the Spliceosome Complex Genes Occur In Adult Patients but Are Very Rare In Children with Myeloid Neoplasia (2011) (0)
- Contemporary Conditioning Regimen before Allogeneic Stem Cell Transplantation for Children with Non-Malignant Diseases (2016) (0)
- Brief report Atypical features of familial hemophagocytic lymphohistiocytosis (2004) (0)
- Next Generation Sequencing Identifies a Novel Subset of Non-Down Syndrome Acute Megakaryoblastic Leukemia Characterized By Chimeric Transcripts Involving HOX Cluster Genes (2015) (0)
- Foxm1 controls a pro-stemness microRNA network in neural stem cells (2018) (0)
- Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin (2016) (0)
- Evidence for permissive and nonpermissive HLA molecular mismatching in MLC: Study in 39 pairs selected for unrelated bone marrow transplantation (1994) (0)
- non-permissive mismatches for hematological stem cell transplantation A T cell epitope encoded by a subset of HLA-DPB1 alleles determines (2013) (0)
- leukemia : results in 3184 patients of the AIEOP-BFM ALL 2000 study children and adolescents with B-cell precursor acute lymphoblastic Molecular response to treatment redefines all prognostic factors in (2010) (0)
- Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Of The AIEOP AML 2002/01 Trial: Screening and Prognostic Impact Of cKIT Mutations (2013) (0)
- Characterization of the immunomodulatory effect in vitro of microvesicles isolated from mesenchymal stromal cells on immune cells (2013) (0)
- Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia (2016) (0)
- Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration (2022) (0)
- Pediatric Acute Megakaryoblastic Leukemia without Down Syndrome: A Retrospective Study by the International Berlin-Frankfurt-Munster Study Group (I-BFMSG) (2014) (0)
- TMOD-14. INNOVATIVE 3D MODEL FOR THE ESTABLISHMENT OF PRIMARY PAEDIATRIC LOW-GRADE GLIOMA (LGG) CULTURES: NEW PLATFORM FOR ADVANCED PRECLINICAL STUDIES OF INNOVATIVE AND IMMUNOTHERAPEUTIC APPROACHES (2019) (0)
- cells SAP controls the cytolytic activity of CD8+ T cells against EBV-infected (2013) (0)
- Allogeneic stem cell transplantation (SCT) from HLA-identical siblings in patients with myelodysplasia or secondary leukemia. (1999) (0)
- Abstract LB-211: NUP98-PHF23 is a novel fusion gene in pediatric cytogenetically normal acute myeloid leukemia (2015) (0)
- Reconstitution of Endothelial Progenitor Cells after Allogeneic Bone Marrow Transplantation in Children with Malignancies. (2005) (0)
- BAG1 Overexpression Restrains the Anti-Apoptotic BCL2, MCL1 and HSP70 Proteins in Acute Myeloid Leukemia. (2012) (0)
- Foreword. New frontiers in molecular and cellular therapy. (2013) (0)
- Insulin Resistance and Abnormal Glucose Tolerance After Paediatric Hematopoietic Stem Cell Transplantation in Blood Cancer Survivors (2015) (0)
- Killer Cell Ig-like Receptors (KIR)-Binding Assay for Tumor Cells (2016) (0)
- O-45 Treatment for patients relapsingwith juvenile myelomonocytic leukemia after allogeneic stem cell transplantation: The EWOG-MDS study (2005) (0)
- Risks and Benefits of Unrelated Donor Peripheral Blood Progenitor Cells (PBPC) in Children and Adolescents with Acute Leukemia. (2008) (0)
- The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment (2021) (0)
- Ex vivo generation and expansion of autologous anti-tumor CTL lines for adoptive cell therapy in patients with solid tumors. (2006) (0)
- HGG-54. HISTOLOGICAL AND MOLECULAR CHARACTERIZATION OF HIGH-GRADE BRAIN TUMORS SECONDARY TO TOTAL BODY IRRADIATION FOR HEMATOLOGICAL MALIGNANCIES (2020) (0)
- of hematologic remission in children with acute myeloid leukemia Emergence of antitumor cytolytic T cells is associated with maintenance (2013) (0)
- AB0149 Activation of indoleamine 2,3-dioxygenase 1 (ido1) in patients with systemic sclerosis (2013) (0)
- Platelet-Lysate for In Vitro Expansion of Human Multipotent Mesenchymal Stromal Cells in Approaches of Cell-Therapy. (2006) (0)
- Results of an AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Randomized Clinical Trial in Children with Low- and Intermediate-Risk Relapsed Acute Lymphoblastic Leukemia (ALL) (2014) (0)
- Clinical Outcome and Immune Recovery after Adoptive Infusion of BPX-501 Cells (donor T cells transduced with iC9 suicide gene) in Children with Hemoglobinopathies and Diamond-Blackfan Anemia Given α/β T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation (HSCT) (2016) (0)
- pure red cell aplasia and hemolytic anemia Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, (2013) (0)
- P.1.186: ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR THALASSAEMIA MAJOR INDUCES IMMUNE TOLERANCE TO GLUTEN IN COELIAC DISEASE (2011) (0)
- MB-64ADOPTIVE CELL IMMUNOTHERAPY IN MEDULLOBLASTOMA BASED ON T CELLS REDIRECTED TOWARD TUMOR CELLS BY PRAME SPECIFIC αβTCR GENE MODIFICATION (2016) (0)
- Unrelated donor cord blood transplantation for children with hematological malignancies (2004) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud (2015) (0)
- Application of Boolean Algebra for Definition of Myeloid Neoplasms (2023) (0)
- High-Throughput RNA Sequencing Analysis Reveals Distinct Molecular Signature in NRAS and PTPN11 JMML Patients (2019) (0)
- C0382 The role of thrombophilia in the perinatal stroke in neonates: A retrospective study in 54 cases (2012) (0)
- Antigen specific cellular therapies (2001) (0)
- Human CD86+ acute myeloid leukemia cells rapidly differentiate into dendritic cells unable of inducing cytotoxic T cell responses. (1999) (0)
- Title: Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and re-definition of inhibitory KIR specificity. Running title: Anti-leukemia alloreactive NK cells in haplo-HSCT AUTHORS: (2008) (0)
- Chromosome anomalies as cause of congenital bone marrow failure syndromes (2015) (0)
- NFB-07. USE OF PEGYLATED INTERFERON α- 2b IN PEDIATRIC PATIENTS AFFECTED BY UNRESECTABLE PLEXIFORM NEUROFIBROMAS: MONOCENTRIC EXPERIENCE (2020) (0)
- Human Mesenchymal Stem Cells Inhibit In Vitro Antibody Production Against Alloantigens. (2005) (0)
- Tuesday, March 28th 09:00-10:30 Oral 8: GVHD (Clinical I) Significant association of IgG glycan structures with intensity of immunosuppression among chronic graft- versus-host disease patients: results of the NIH cohort study (2017) (0)
- T Cell-Mediated Control of HCMV Infection in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation. (2004) (0)
- Microscopic neoplastic thrombosis in localised nephroblastoma: does it influence outcome? (2011) (0)
- Clinical and Biological Characterization of Children with FLT3ITD Mutated Acute Myeloid Leukemia (AML): A Report from the AIEOP AML-2002 Study Group (2015) (0)
- Evaluation of balance disorders in children with posterior cranial fossa tumour (2014) (0)
- NPM1 Mutational Status Underlines Different Biological Features in Pediatric AML (2021) (0)
- Unrelated hematopoietic stem cell transplantation for Thalassemia: 15 years of experience of the italian group "GITMO" (2011) (0)
- Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis Biology of Blood and Marrow Transplantation (2016) (0)
- Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib— the Italian Experience (2017) (0)
- The Optimal Alternative Donor Transplant for Pediatric Patients with Acute Leukemia: A Comparison between Alfa-Beta T-Cell and B-Cell Depleted Haplo-SCT and UCBT (2018) (0)
- perforin gene A proportion of patients with lymphoma may harbor mutations of the (2013) (0)
- Gene therapy, cellular immunotherapy and vaccination-Clinical (2020) (0)
- TMOD-05. GENOME-WIDE DNA METHYLATION PROFILE: A POWERFUL STRATEGY TO RECAPITULATE HETEROGENEITY OF PEDIATRIC BRAIN TUMORS IN PRIMARY CELL LINES (2021) (0)
- KIR Workshop 25th‐27th October 2018 ‐ Camogli (GE) Italy (2019) (0)
- LONG TERM Outcomes of Pediatric Patients with Malignant and NON-Malignant Disorders Receiving Α/Β T-CELL Depleted HLA-Haploidentical Hematopoietic STEM CELL Transplantation (HSCT) Followed by Infusion of BPX-501 T CELLS (DONOR T CELLS Transduced with IC9 (2017) (0)
- PB2355 A PHASE I/II, OPEN-LABEL, SINGLE-ARM, STUDY OF RUXOLITINIB ADDED TO CORTICOSTEROIDS IN PEDIATRIC PATIENTS WITH ACUTE GRAFT-VS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (REACH-4) (2019) (0)
- leukemia: a Eurocord group analysis Unrelated cord blood transplantation for childhood acute myeloid (2013) (0)
- PDTM-09. DIFFUSE INTRINSIC PONTINE GLIOMA AND PEDIATRIC GLIOBLASTOMA DERIVED-EXOSOMES HAVE SPECIFIC ONCOGENIC SIGNATURES (2018) (0)
- The reconstitution of cellular immunity after bone marrow transplantation in children. (1992) (0)
- Outcome of Children with Wiskott-Aldrich Syndrome (WAS) Given TCR Alpha-Beta/CD19 Depleted Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Haploidentical Relative (2021) (0)
- A National Retrospective Analysis of Data from the Italian Association of Pediatric Hematology Oncology (AIEOP). (2015) (0)
- Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome (2010) (0)
- Remission State Subset Dynamics and Correlates with − CD 4 and + Transplantation Defines Distinct CD 4 HLA-Haploidentical Stem Cell Pediatric Leukemia Patients Given Invariant NKT Cell Reconstitution in Dellabona and Giulia (2011) (0)
- Umbilical cordblood transplantation (1998) (0)
- NOVEL Recurrent Genetic Aberrations in Pediatric AML: An AIEOP AML-2002 Study Group. (2012) (0)
- Haploidentical Hematopoietic Cell Transplantation in Children with Neoplastic Disorders (2018) (0)
- MicroRNA profiling of pediatric low-grade gliomas (pLGGs) (2016) (0)
- PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF THE CD56DIMCD16LOW NK CELL SUBSET IN BONE MARROW AND PERIPHERAL BLOOD OF HEALTHY DONORS. (2013) (0)
- IN VITRO CHARACTERIZATION OF BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS (MSCS) FROM PATIENTS WITH CROHN'S DISEASE (CD) (2009) (0)
- Dendritic cells pulsed with leukemia blasts elicit jw vitro potent anti-leukemia cytotoxic t-cell response in patients given allogeneic bone marrow transplantation and in their donors (2000) (0)
- A New Insight into Pediatric Leukemia: Che-1 Involvement in Oncogenic c-Myc Signaling (2016) (0)
- IMMUNOLOGICAL PROPERTIES OF BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS (MSCS) FROM CROHN'S DISEASE (CD) PATIENTS (2009) (0)
- Late Effects of HSCT (2011) (0)
- Abstract A29: Notch-dependent modulation of microRNAs in rhabdomyosarcoma (2012) (0)
- Infectious Complications of HSCT (2011) (0)
- Abstract 970: Circulating microRNA signature in group 4 medulloblastoma patients (2016) (0)
- Epstein-Barr virus and Herpes simplex virus specific cytotoxic T-lymphocyte activity after bone marrow transplantation in pediatric patients: Pattern of recovery and correlation with virus-specific immune status of the donor (1994) (0)
- Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells isolated from pediatric patients affected by acute lymphoblastic leukemia (2013) (0)
- Adenovirus Specific T-Cell Lines Devoid of Alloreactivity Against Haploidentical Recipients Can Be Obtained Using a Set of Adenovirus Hexon Peptides. (2007) (0)
- Febuxostat Pharmacokinetic/Pharmacodynamic Bridging from Adults to Pediatrics for Effective Prophylaxis of Tumor Lysis Syndrome: From Florence to Floret Study (2015) (0)
- Low incidence of GvHD and rejection after pharmacological ex vivo modulation of bone marrow in 2-3 antigens mismatched BMT. (1993) (0)
- BFM-type chemotherapy for childhood acute lymphoblastic leukemia impairs pubertal spurt and causes moderate adult height loss (2003) (0)
- Allogeneic peripheral blood stem cell transplantation following reduced-intensity chemotherapy for refractory sarcoma (2001) (0)
- HLA-DPB1 disparity in host-versus-graft direction transplantation for thalassemia is associated with nonpermissive Graft rejection after unrelated donor hematopoietic stem cell (2011) (0)
- Bone marrow transplantation for leukaemia: the role of total body irradiation, graft vs host disease, and haemopoietic chimerism. (1989) (0)
- A Complex Karyotype but Not Monosomy 7 Is an Independent Prognostic Factor in Advanced Childhood MDS. (2007) (0)
- Pivotal Role of Dosimetry in High Activity 131i Mibg Therapy in Patients Affected by High Risk Relapsed Refractory Neuroblastoma: Towards a Deeper Metastatic Response Understanding (2021) (0)
- Outcomes After Related and Unrelated Umbilical Cord Blood Transplantation for Congenital Bone Marrow Failure Syndromes Other Than Fanconi Anemia. (2009) (0)
- Safety of Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis (HLH): Relationship to Treatment Exposure (2021) (0)
- KIR AND THEIR HLA CLASS 1 LIGANDS CAN HELP REFINE DONOR SELECTION CRITERIA FOR THALASSEMIA PATIENTS UNDERGOING UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION (2012) (0)
- Long-Term Outcome of Relapsed Acute T-Lymphoblastic Leukemia (T-ALL) in Children and Adolescents (2019) (0)
- Myelodysplastic syndromes in adolescents: characteristics and clinical outcome (2009) (0)
- Pharmacokinetic Results Of a Feasibility and Phase II Study (ITCC 021) On Bortezomib (BTZ) In Pediatric Relapsed ALL: Lack Of Significant Penetration Of BTZ In The Cerebrospinal Fluid (2013) (0)
- A New Enzyme-Linked Immunosorbent Assay for a Total Anti-T Lymphocyte Globulin Determination: Development, Analytical Validation, and Clinical Applications (2017) (0)
- Clinical Outcome and Immune Recovery after Adoptive Infusion of BPX-501 Cells (donor iC9-transduced T cells) in Children with Wiskott-Aldrich Syndrome (WAS) Given Alfa/Beta T-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) (2016) (0)
- Poor Prognosis in Children with ABL-Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols (2019) (0)
- Stimulation of CB2 directly stimulates cell survival pathways. (2013) (0)
- Renal transplantation - clinical studies - 2 (2009) (0)
- A case of microcytic anemia. (1998) (0)
- Busulfan, Cyclophosphamide and Melphalan As Conditioning Regimen for Pediatric Patients with AML in 1st or 2nd CR: A Retrospective Analysis from the AIEOP HSCT Registry (2018) (0)
- OC.12.3 IMMUNOMODULANT EFFECTS OF MESENCHYMAL STROMAL CELLS (MSC) ON GLIADIN-SPECIFIC T CELL LINES (2013) (0)
- Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. the Italian Experience (2015) (0)
- Improving nelarabine efficacy in refractory/relapsed T-cell acute lymphoblastic leukemia (T-ALL) by targeting aberrant PI3K/mTOR signaling (2016) (0)
- MESENCHYMAL STROMAL CELL TREATMENT IN CHILDREN WITH ACUTE GVHD. TIME FOR A RANDOMIZED STUDY OF EARLY INTERVENTION (2010) (0)
- Minimal Residual Disease and Outcome Characteristics in Infant KMT2A-Germline Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol (2021) (0)
- 233 IER3 in childhood myelodysplastic syndrome (2011) (0)
- P079 BRAF mutations in juvenile myelomonocytic leukemia (2007) (0)
- Prospective study of endocrine side-effects following bone marrow transplantation in childhood. (1991) (0)
- 2012 – ADAPTIVE AND MALADAPTIVE SOMATIC RESCUE MOSAICISM IN SAMD9 AND SAMD9L SYNDROMES EXEMPLIFIES THE HIGH PLASTICITY OF HEMATOPOIESIS EARLY IN LIFE (2021) (0)
- Inotuzumab Ozogamicin (InO) Combined with UKALL-R3 Modified Chemotherapy in Pediatric Patients with B-Cell Precursor CD22+ Acute Lymphoblastic Leukemia (BCP-ALL) - Results from the ITCC-059 Phase 1B Trial (2022) (0)
- Microarray expression studies on bone marrow of patients with Shwachman-Diamond syndrome in relation to deletion of the long arm of chromosome 20, other chromosome anomalies or normal karyotype (2020) (0)
- [The "staging" problem in chronic lymphatic leukemia. Remarks about 223 cases observed in prospect starting from diagnosis (author's transl)]. (1979) (0)
- Long-term Outcomes of 63 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed-up to 7 Years after Treatment with betibeglogene autotemcel (beti-cel) Gene Therapy (GT) and Factors Impacting Neutrophil and Platelet Engraftment (2023) (0)
- Alpha-beta T and B-cell depleted HLA-haploidentical HSCT in children with myelodysplastic syndromes. (2022) (0)
- LGG-18. EVEROLIMUS TREATMENT IN PEDIATRIC PATIENTS AFFECTED BY LOW-GRADE GLIOMAS (pLGG) NON-TSC, BRAF v600-WT (2020) (0)
- Impact of Additional Intensive L-Asparaginase Therapy during Consolidation Phase for High-Risk Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial in the AIEOP-BFM ALL 2009 Protocol (2022) (0)
- Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP) (2018) (0)
- Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma (2017) (0)
- Acute Hepatitis-Like Presentation of Graft-versus-Host Disease following Donor Lymphocyte Infusion (2003) (0)
- P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA (2022) (0)
- 4108 Reduced intensity conditioning regimen and allogeneic stem cell transplantation from related or unrelated HLA identical donor in high risk neuroblastoma (2009) (0)
- High-dose chemotherapy/ABMT in 72 patients with advanced resistant Hodgkin's disease (HD). An Italian study group (1988) (0)
- International Symposium Frontiers of Paediatric Neuroendocrinology (1993) (0)
- The BTN162b2 Vaccine Induces Humoral and Cellular Immune Memory to Wuhan Strain SARS-CoV-2 and the Omicron Variant in Children 5 to 11 Years of Age (2022) (0)
- Comparison of Emapalumab with Conventional Treatment in Patients with Primary Hemophagocytic Lymphohistiocytosis (HLH): Consistent Results Obtained in an Unadjusted and an Adjusted Analysis (2020) (0)
- Repurposing anthelmintic agents to eradicate resistant leukemia (2020) (0)
- Early Versus Late Treatment with Ruxolitinib in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease: A Post Hoc Analysis from the Randomized, Phase 3 REACH3 Study (2022) (0)
- CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment (2017) (0)
- Updated Analysis on the Outcomes of Children with Acute Leukemia (AL) Receiving an Alpha/Beta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) (2022) (0)
- Ruxolitinib for Chronic Graft-versus-Host Disease. Reply. (2021) (0)
- AML-283 The Genetic Landscape of NUP98-Rearranged Pediatric Leukemia. (2022) (0)
- Post-Transplant Outcomes of Children with Primary Hemophagocytic Lymphohistiocytosis Treated with Emapalumab (2021) (0)
- Treatment Duration, Symptom Resolution, and Survival in Defibrotide-Treated Patients with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation: Pooled Analysis of Defifrance and EBMT PASS Registries (2022) (0)
- The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Award Winners (O001-O007) (2022) (0)
- Specific Cytogenetic Abnormalities at Diagnosis Predict Survival after Hematopoietic Cell Transplant in Poor-Risk Pediatric Acute Myeloid Leukemia: A PDWP/EBMT Study (2022) (0)
- The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT (2022) (0)
- Incidence and Therapeutic Implications of Germline TP53 Mutations in Hypodiploid Childhood Acute Lymphoblastic Leukemia: A Retrospective Analysis of the Italian Cohort (2020) (0)
- Long Term Outcomes of 63 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed up to 7 Years Post-Treatment with betibeglogene autotemcel (beti-cel) Gene Therapy and Exploratory Analysis of Predictors of Successful Treatment Outcomes in Phase 3 Trials (2022) (0)
- Outcome of Haematopoietic Cell Transplantation in 813 Children with Fanconi Anaemia: A Study on Behalf of the EBMT Severe Aplastic Anaemia Working Party and Paediatric Disease Working Party (2022) (0)
- Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group. (2023) (0)
- [Graft vs host disease in a child undergoing allogeneic bone marrow transplantation]. (1991) (0)
- Long Term Results of the AIEOP-All-95 Trial for Childhood Acute Lymphoblastic Leukemia. An Insight on the Prognostic Value of Dna Index in the Frame of BFM-Based Chemotherapy. (2007) (0)
- PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 (2022) (0)
- Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^ (2021) (0)
- Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor. (2023) (0)
- Impact of Donor and Patient CMV Serology in Children Receiving First Geno-Identical or Unrelated HSCT for Malignant Hematological Disease: An EBMT Retrospective Registry Study (2022) (0)
- Relapse Is the Most Common Treatment Failure Post HSCT in Children with ALL below 4 Years of Age Given a Chemo-Based Conditioning Regimen. Results from the Prospective Multinational Forum-Trial (2022) (0)
- P398: DEVELOPMENT AND CHARACTERIZATION OF PRECLINICAL IN VIVO MODELS FOR THE IDENTIFICATION AND TESTING OF NEW THERAPEUTIC APPROACHES FOR PEDIATRIC ACUTE MYELOID LEUKEMIA (2022) (0)
- Outcome of Children Developing Grade III-IV Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation (2019) (0)
- P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL (2022) (0)
- Long-Term Patient-Reported Outcomes Following Treatment with betibeglogene autotemcel in Patients with Transfusion-Dependent β-Thalassemia (2022) (0)
- BRENTUXIMAB-BENDAMUSTINE IN CHILDREN, ADOLESCENT AND YOUNG ADULTS WITH RELAPSED/REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA (2022) (0)
- Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study (2021) (0)
- 3138 – HIGH CHROMOSOME INSTABILITY ACROSS ANEUPLOID SUBTYPES OF CHILDHOOD B-CELL ALL AND POTENTIAL ASSOCIATION WITH DISEASE PROGRESSION IN PDX MODELS. (2022) (0)
- Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia (TDT) or Sickle Cell Disease (SCD): Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-Cas9-Modified CD34+ Hematopoietic Stem and Progenitor Cells (HSPCs) (2021) (0)
- S1635 ACADEMIC, PHASE1 TRIAL ON T CELLS EXPRESSING BOTH CD19 CHIMERIC ANTIGEN RECEPTOR AND INDUCIBLE CASPASE 9 SAFETY SWITCH FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA AND NON-HODGKIN LYMPHOMA (2019) (0)
- P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) (2022) (0)
- SAFETY AND EFFICACY EVALUATION OF EX VIVO EXPANDED CORD BLOOD PROGENITOR CELLS FOR ALLOGENIC TRANSPLANTATION IN A PHASE I/II STUDY (2006) (0)
- First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha-mannosidosis. (2023) (0)
- TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia. (2023) (0)
- CD72 Is a Pan-Tumor Antigen Associated with Childhood Acute Leukemia (2022) (0)
- Mutation Analysis in the Sbds Gene in a Group of Italian Patients Affected by Shwachman Diamond Syndrome (2003) (0)
- Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS (2014) (0)
- PATH-19. MOLECULAR CLASSIFICATION BASED ON THE DNA METHYLATION PROFILE OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS IN CHILDREN: TWO-YEARS EXPERIENCE AT THE BAMBINO GESÙ HOSPITAL (2020) (0)
- Session G: Lymphoma, Leukemia and Melanoma G1 ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) WITH NON-MYELOABLATIVE CONDITIONING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS (2004) (0)
- Mucosal-Associated Invariant T (MAIT) Cells Are Functionally Impaired in Pediatric Patients Following HCT and Their Recovery Is Associated with the Onset of GvHD (2022) (0)
- Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft (2023) (0)
- Brief Report (2013) (0)
- Proteomics of Aqueous Humor as a Source of Disease Biomarkers in Retinoblastoma (2022) (0)
- Superior Graft-Versus-Leukemia Effect in Matched Unrelated Donor Versus HLA-Identical Sibling Pediatric Recipients Transplanted for Acute Lymphoblastic Leukemia within the Forum Study (2022) (0)
- Favorable Outcome of Children with Acute Megakaryoblastic Leukemia Treated with the AIEOP AML 2002/01 Protocol (2012) (0)
- Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia, a PDWP/EBMT Study (2022) (0)
- Intrabone Injection of T-Cell Depleted Peripheral Blood Stem Cells from HLA-Haploidentical Donors to Reduce the Risk of Graft Rejection in Children (2014) (0)
- Mesenchymal Stromal Cell Secretome in Acute Myeloid Leukemia Bone Marrow Niche (2022) (0)
- Long-Term Data Confirm the Superiority of Total Body Irradiation-Containing Conditioning Regimen in Comparison to a Chemotherapy-Based Preparation in Children with Acute Lymphoblastic Leukemia Above the Age of 4 Years Given an Unmanipulated Allograft. Results of the Forum Randomized Clinical Trial (2022) (0)
- Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (2021) (0)
- Treatment (Tx) Duration, Symptom Resolution, and Survival in Defibrotide (DF)-Treated Patients (pts) with Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Cell Transplantation (HCT): Analysis of a Multinational, Prospective, Observational Registry Study (2021) (0)
- Mutational Screening in refractory cytopenia - in search of underlying SDS. (2009) (0)
- Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia (2012) (0)
- Response to: meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data. (2023) (0)
- Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (2018) (0)
- Safety and Efficacy Outcomes in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT) Receiving Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies (2021) (0)
- S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B-CELL NON-HODGKIN LYMPHOMA (NHL): THE PHASE II BIANCA STUDY (2022) (0)
- Population Pharmacokinetics of Inotuzumab Ozogamicin (InO) As Single Agent in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia - Results from the ITCC-059 Phase IA and Phase II Trial (2022) (0)
- Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles (2023) (0)
- PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients (2019) (0)
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma (2012) (0)
- Secondary Mutations of JAK3 and SETBP1 in Juvenile Myelomonocytic Leukemia and Their Propagating Capacity; A Report from the AIEOP Study Group (2014) (0)
- Abstract B62: Cell cycle alterations in paired diagnosis-relapse childhood acute lymphoblastic leukemia. (2013) (0)
- Abstract 5207: Mitoxantrone in combination with TGFβ and PD-1 blockade remodels the tumor immune landscape enhancing neuroblastoma antitumor immunity (2022) (0)
- Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma (2019) (0)
- Abstract 3792: SKP2 supports cell proliferation and is regulated by Notch signaling in myoblasts and embryonal rhabdomyosarcoma (2015) (0)
- GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma. (2023) (0)
- Indoleamine 2,3-dioxygenase-1 (IDO1) expression by childhood acute myeloid leukemia restrains IFN-γ production by T cells and may portend an unfavorable prognosis (P2157) (2013) (0)
- T Cell Immunotherapy for Immune Reconstitution and GVHD Prevention After Allogeneic Hematopoietic Stem Cell Transplantation (2015) (0)
- Correction: JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction (2020) (0)
- Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup (2015) (0)
- EPCO-02. GENOME-WIDE DNA METHYLATION PROFILING AND GENETIC CHARACTERIZATION OF LONG-TERM SURVIVAL IDH WILD-TYPE GLIOBLASTOMA PATIENTS (2022) (0)
- Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders (2019) (0)
- MEDB-46. ONC201 affects Group 3 Medulloblastoma growth by impairing cancer stem cells (2022) (0)
- Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. (2023) (0)
- Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response (2023) (0)
- severe/refractory intestinal Behcet disease Autologous hematopoietic stem cell transplantation for (2011) (0)
- HGG-44. Unraveling and Targeting the stem-regulatory network driving invasion in Diffuse hemispheric glioma, H3G34-mutant (2022) (0)
- Cysteamine treatment restores the in vitro ability to differentiate along the osteoblastic lineage of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient (2015) (0)
- Single-dosed exa-cel leads to early and durable increase of foetal haemoglobin (2022) (0)
- UNCAN.eu, a European initiative to UNderstand CANcer. (2022) (0)
- A refined approach to detect and measure minimal residual disease in childhood acute myeloid leukemia by flow cytometry (2014) (0)
- Phase 2 Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) (2021) (0)
- Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma (2015) (0)
- Molecular Aberrations in 107 Children with Myelodysplastic Syndrome (MDS). (2012) (0)
- The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors (2023) (0)
- Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications (2019) (0)
- Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts (2014) (0)
- Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma (2021) (0)
- The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age (2022) (0)
- β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells (2017) (0)
- A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia (2023) (0)
- Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features (2014) (0)
- A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation (2021) (0)
- Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS (2017) (0)
- MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression (2022) (0)
- Commentary to the ESPE Statements on the Safety of Human Growth Hormone Therapy (1993) (0)
- Reversible induction of mitophagy by an optogenetic bimodular system (2019) (0)
- Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (2021) (0)
- Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation (2023) (0)
- Hematopoietic Stem Cell Transplantation in Thalassemia. (2023) (0)
- Abstract 3749: Mapping the DNA accessibility landscape of BCP-ALL patients revealed principles of tumor evolution (2022) (0)
- JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction (2020) (0)
- Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration (2022) (0)
- Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma (2015) (0)
- A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease (2022) (0)
- CAR.CD123-NK Cells Have an Equally Effective but Safer Off-Tumor/on-Target Profile As Compared to CARCD123-T Cells for the Treatment of Acute Myeloid Leukaemia (2022) (0)
- PTPS-03EPIGENETIC SILENCING OF β-ARRESTIN1 AND ITS INTRAGENIC miR-326 CONTROLS MEDULLOBLASTOMA GROWTH (2015) (0)
- Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients. (2023) (0)
- SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity (2023) (0)
- HGG-19. IDENTIFICATION OF NOVEL SUBGROUP-SPECIFIC miRNA EXOSOMAL BIOMARKERS IN PEDIATRIC HIGH-GRADE GLIOMAS (2020) (0)
- Paediatric Acute Lymphoblastic Leukaemia (ALL) (2022) (0)
- Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet) (2019) (0)
- FGFR1 is a potential therapeutic target in neuroblastoma (2022) (0)
- Preclinical Development of a CAR-T Cell Approach Targeting the CD84 Antigen Associated to Pediatric Acute Myeloid Leukemia (2022) (0)
- Modeling medulloblastoma in vivo and with human cerebellar organoids (2020) (0)
- Cow's milk allergy non‐responsive to amino acid‐based formula? A successful transplanted patient with immune dysregulation, polyendocrinopathy, enteropathy, and X‐linked syndrome (2021) (0)
- Abstract 668: A MYOD-SKP2 axis boosts oncogenic properties of fusion negative rhabdomyosarcoma and is counteracted by neddylation inhibition in vitro and in vivo (2022) (0)
- β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum (2023) (0)
- Updated safety and efficacy data from an open-label, phase 1/2 study of frontline brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) in pediatric patients with advanced-stage classical Hodgkin lymphoma (cHL). (2022) (0)
- Efficacy and Safety of Betibeglogene Autotemcel (beti-cel) Gene Therapy in 63 Patients with Transfusion-Dependent β-Thalassemia (TDT): 7-Year Post-Infusion Follow-up of Phase 1/2 and Phase 3 Studies (2022) (0)
- MiR-1248 a New Biomarker for Progression Risk Stratification of Incompletely Resected Supratentorial Hemispheric Pediatric Low-Grade Gliomas (2022) (0)
- The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in Children (2023) (0)
- HGG-43. Abrogation of exosome biogenesis significantly affects cell motility in heterogenous sub-populations of paediatric-type diffuse high-grade glioma (2022) (0)
- Fourth international workshop on haploidentical transplants, Naples, Italy (2004) (0)
- The Integrated Immunological Signature of Refractory Cytopenia of Childhood (RCC) (2015) (0)
- Measuring the Confluence of iPSCs using an Automated Imaging System. (2020) (0)
- Enhancer plasticity sustains oncogenic transformation and progression of B-Cell Acute Lymphoblastic leukemia (2022) (0)
- RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia (2017) (0)
- Graft-Versus-Leukemia Effect Is Equivalent in Recipients of Matched Sibling and Matched Unrelated Donor Conventional Hematopoietic Cell Transplant. (2007) (0)
- ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism (2021) (0)
- Erratum: In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: Results of a multicentre observational study (Bone Marrow Transplantation (2013) 48 (908-914) DOI: 10.1038/bmt.2013.66)) (2013) (0)
- Indications for Hematopoietic Stem Cell Transplantation in Children (2018) (0)
- Peptide Loading on MHC Class I Molecules of Tumor Cells (2016) (0)
- Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience (2014) (0)
- Case 37-1994: juvenile chronic myelogenous leukemia. (1995) (0)
- Session H: CNS, Melanoma and Sarcoma HI AIXOGENEIC BLOOD STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CHEMOTHERAPY FOR REFRACTORY SARCOMA (2005) (0)
- Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome. (2023) (0)
- Second A llogeneic B one M arrow T ransplantation i n A cute Leukemia: R esults o f a S urvey b y t he E uropean Cooperative G roup f or B lood a nd M arrow T ransplantation (2001) (0)
- Risk-adapted treatment of acute promyelocytic leukemia : results from International Consortium for Childhood APL Running title : risk-adapted therapy for childhood APL (2018) (0)
- Aberrant DNA Methylation Characterizes a Subtype of Juvenile Myelomonocytic Leukemia (JMML) with Poor Outcome. (2009) (0)
- Mosaic Distribution of RAS Pathway Mutated and Non Mutated Cells in Bone Marrow of Juvenile Myelomonocytic Leukemia. (2012) (0)
- Graft Versus Host Disease (GVHD) and Rejection (2011) (0)
- Outcome of children with ALL in second CR transplanted from an unrelated donor has significantly improved over time and is favourably influenced by the occurrence of grade I-II acute GVHD and limited chronic GVHD (2013) (0)
- improved using the mother as donor Survival after T-cell depleted haploidentical stem cell transplantation is (2013) (0)
- CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS (2007) (0)
- Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients Older Than 60 Years. (2004) (0)
- Application of Mathematical Logic for Cytogenetic Definition and Risk Stratification of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) (2021) (0)
- Gene therapy of haemoglobinopathy: An Italy-USA project (2010) (0)
- Patient-Reported Outcomes (PROs) Among Patients With Steroid-Refractory or -Dependent Chronic Graft-vs-Host Disease (cGVHD) Randomized to Ruxolitinib (RUX) vs Best Available Therapy (BAT) (2021) (0)
- Phenotypical and functional characterization of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient (2014) (0)
- Non-hla genetic polymorphisms and haemopoietic stem cells transplantation (2005) (0)
- Corrigendum (2017) (0)
- IER3 expression in childhood myelodysplastic syndrome (2011) (0)
- Erratum to: Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients (2017) (0)
- Supportive therapy after bone marrow transplantation. AIEOP BMT Group. (1989) (0)
- Thrombotic Thrombocytopenic Purpura after Allogeneic Hematopoietic Stem Cell Transplantation: A Complication Still Frequent and Responsible of Severe Outcome. (2005) (0)
- Effect of Notch3 to regulate rhabdomyosarcoma growth in vitro and in vivo. (2011) (0)
- OC3.05.6 DOES ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) REINDUCE IMMUNE TOLERANCE TO GLUTEN IN COELIAC DISEASE (2008) (0)
- Sensitivity Analysis of Overall Response Rate (ORR) with Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis (HLH) (2020) (0)
- New Therapeutic Opportunities for Pediatric Patients with t(6;11)-Rearranged Acute Myeloid Leukemia (2016) (0)
- Influence of Cytogenetic, Molecular Abnormalities and Other Risk Factors on the Outcomes of Children with Acute Myelogenous Leukemia Given An Unrelated Cord Blood Transplantation. A Survey on Behalf of Eurocord, ALWP and PDWP of EBMT (2011) (0)
- Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale (2023) (0)
- Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Enrolled In The AIEOP AML 2002/01 Trial: The Impact Of Minimal Residual Disease On Patient Outcome (2013) (0)
- Additional file 4: Figure S4. of Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway (2016) (0)
- 232 Relevance of WT1 expression, mutations and single nucleotide polymorphisms in juvenile myelomonocytic leukemia (2011) (0)
- transplanted for acute lymphoblastic leukemia in second remission No difference in outcome between children and adolescents (2011) (0)
- An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT (2015) (0)
- Immunomodulatory Properties of MSCs (2013) (0)
- Three-Drug Induction and BFM-Type Intensive Consolidation Chemotherapy for Treatment of Standard Risk Childhood Acute Lymphoblastic Leukemia Defined Also by DNA index. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Study ALL-9501. (2004) (0)
- Post-transplant emergence and persistence of leukemia-specific CTLp is associated with a lower risk of relapse. (1998) (0)
- Stem Cells in Hematology (166 articles) (2005) (0)
- Deferoxamine in thalassemia major. (1995) (0)
- HUMAN MESENCHYMAL STEM CELLS INHIBIT ANTIBODY PRODUCTION INDUCED IN VITRO BY ALLOSTIMULATION OF LYMPHOCYTES FROM SENSITIZED KIDNEY RECIPIENTS (2006) (0)
- Response of Patients with Transfusion-Dependent β-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-Thalassemia) Gene Therapy Based on HBB Genotype and Disease Genetic Modifiers (2020) (0)
- OR.69. Alloreactive NK Cells Exert Anti-leukemia Activity in Haplo-HSCT to Pediatric Patients: Revised Role of Activating and Inhibitory KIR (2009) (0)
- Notch3 and HES1 nuclear protein staining is positive in primary RMS tissues. (2014) (0)
- Successful In Vitro Priming of EBV-Specific CD8+ T Cells Endowed with Strong Cytotoxic Function for Prophylaxis or Treatment of PTLD in EBV Seronegative Hosts. (2005) (0)
- Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis (2018) (0)
- High Treosulfan Exposure is Associated with Early Toxicity in Pediatric Hematopoietic Stem Cell Transplantation: A Prospective Multicenter Study (2018) (0)
- Outcome of Children with Different Non-Malignant Disorders Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) (2020) (0)
- Exposure to ionizing radiations and starvation culture does not modify phenotype, functions and genetic profile of mesenchymal stromal cells isolated from bone marrow of healthy donors (2013) (0)
- Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation (2022) (0)
- EFIS‐EJI Travel Grants for ECI 2018 (2018) (0)
- Outcome of Allogeneic HSCT after Chemo-Based Conditioning in Infants with Acute Myeloid Leukemia in First Complete Remission: A Multicenter EBMT-PDWP Study (2021) (0)
- Juvenile myelomonocytic leukemia : five genes, how many subtypes? (2014) (0)
- Stable Expression of Chimeric Antigen Receptors by Sleep- ing Beauty Transposon System and Efficient Expansion of Leukemia-Specific Cytotoxic Cells (2014) (0)
- Analysis of Hospitalization Events in Patients with Primary Hemophagocytic Lymphohistiocytosis (HLH) Treated with Emapalumab (2020) (0)
- BRAF Mutations in Juvenile Myelomonocytic Leukemia. (2007) (0)
- Allogeneic bone marrow transplantation in children from other than HLA-identical sibling donor. (1991) (0)
- Decision Models for Cost-Effectiveness Analysis: A Means for Knowledge Sharing and Quality Control in Health Care Multidisciplinary Tasks (1995) (0)
- Characterization of the in vitro immunomodulatory properties of microvesicles isolated from mesenchymal stromal cells (2014) (0)
- Fludarabine, Cyclophosphamide, Anti-Thymocyte Globulin, with or without “ 2Gy TBI, for Alternative Donor Transplants in Acquired Aplastic Anemia (SAA): A Report From the EBMT-SAA Working Party. (2009) (0)
- A Landmark Analysis of Survival by Response Category in Elderly Patients with Acute Myeloblastic Leukemia (2001) (0)
- Contents Vol. 164, 2014 (2014) (0)
- Juvenile myelomonocytic leukemia (2012) (0)
- Phase I study to evaluate dose, safety and tolerability of the polo-like kinase inhibitor Volasertib in paediatric patients with acute leukaemia and advanced solid tumours (2016) (0)
- IMMU-13. DUAL IGF1R/IR INHIBITOR IN COMBINATION WITH GD2-CAR T-CELLS AS A POTENT THERAPEUTIC STRATEGY FOR H3K27M-MUTANT DIFFUSE MIDLINE GLIOMAS (2020) (0)
- Subject Index, Vol. 36, 1991 (1991) (0)
- 107 Safety and efficacy of a caspofungin-based combination therapy for the treatment of invasive mycoses in pediatric hematological patients (2006) (0)
- MBCL-18. ANALYSIS OF DNA METHYLATION PROFILES OF PEDIATRIC MEDULLOBLASTOMAS: EXPERIENCE AT THE BAMBINO GESÙ CHILDREN’S HOSPITAL (2020) (0)
- JAG1 and DLL1 down-regulation inhibits Notch3 cleavage and impairs RMS cell proliferation. (2014) (0)
- HLA-Haploidentical TCR αβ/CD19-Depleted Hematopoietic Stem Cell Transplantation in Children with Fanconi Anemia (2016) (0)
- Hematopoietic Cell Transplantation for Children with High Risk Acute Lymphoblastic Leukemia in First Complete Remission: A Report From the Italian Association of Pediatric Hematology and Oncology (AIEOP) Registry. (2012) (0)
- autoimmunity/lymphoproliferation and defective Fas function Variations of the perforin gene in patients with (2012) (0)
- 118: Co-transplanation of haploidentical mesenchymal stem cells to overcome graft dysfunction associated with parental haploidentical CD34 postive selected peripheral stem cell grafts (2007) (0)
- High Dose Imatinib Is Effective In Children and Adolescents With Chronic Myelogenous Leukemia In Chronic Phase. The Italian Experience (2013) (0)
- S1632 SAFETY AND EFFICACY OF LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT B-THALASSAEMIA AND NON-B0/B0 GENOTYPES IN THE PHASE 3 NORTHSTAR-2 STUDY (2019) (0)
- Literature Reviews: Hematology/Oncology: Antilymphocyte Globulin, Cyclosporin, and Granulocyte Colony-Stimulating Factor in Patients with Acquired Severe Aplastic Anemia (SAA): A Pilot Study of the EBMT SAA Working Party (1995) (0)
- OC1.08.5 AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STEM CELL INFUSION IN CROHN'S DISEASE PATIENTS WITH FISTULAS (2008) (0)
- Parents’ Commitment to Participation in Mesenchymal Stem Cell Donation and Research Demonstrates Extensive Altruism to Other Patients. (2007) (0)
- childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study Late MRD response determines relapse risk overall and in subsets of (2013) (0)
- Characteristics and outcome of treatment-related MDS after childhood cancer: The EWOG-MDS experience (2006) (0)
- MSCs for Gastrointestinal Disorders (2013) (0)
- In Vitro Expanded MSCs From Patients with Myeloprliferative Neoplasms at Late Passages Show Recurrent Cytogenetic Abnormalities (2010) (0)
- [The adolescent with chronic disease: the oncohematologic pathology]. (2001) (0)
- Risk Factors of Outcomes after Haploidentical Hematopoietic Stem Cell Transplants for Children with High Risk Acute Leukaemia. A Survey on Behalf of the EBMT. (2005) (0)
- Quantification by Superconducting Quantum Interference Device (SQUID) of Iron Overload after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). (2008) (0)
- Cell therapy with EBV-specific cytotoxic T-lymphocytes for patients with nasopharingeal carcinoma. (2010) (0)
- HSCT from Alternative Sources and Donors (2011) (0)
- Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with GATA2-Related Myelodysplastic Syndrome (2019) (0)
- Risks and Benefits of Unrelated Donor Peripheral Blood Progenitor Cell S (PBSC) in Children and Adolescents With Acute Leukemia (2009) (0)
- Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol. (2009) (0)
- Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia. (2023) (0)
- Significance of the Philadelphia Chromosome in Acute Leukemias: Variable Correlation with Rearrangements Involving the c‐Abl and Bcr Genes a (1987) (0)
- Abstract 2065: Targeting the crosstalk between MET and Notch signaling in Rhabdomyosarcoma (2017) (0)
- BPX-501 Cells (donor T cells transduced with iC9 suicide gene) Are Able to Clear Life-Threatening Viral Infections in Children with Primary Immune Deficiencies Given Alpha/Beta T-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT) (2015) (0)
- HGG-16. EXOSOME-MEDIATED INTER-CLONAL INTERACTIONS IN PEDIATRIC GBM AND DIPG (2020) (0)
- IMMU-12. NOVEL APPROACH FOR THE TREATMENT OF PEDIATRIC HIGH-GRADE GLIOMAS WITH THE COMBINATION OF ONCOLYTIC ADENOVIRUSES AND GENE THERAPY ENCODING A BiTE DIRECTED TO THE EphA2 TUMOR ANTIGEN. (2019) (0)
- Pembrolizumab (and friends) in pediatric malignancies: should we consider Hodgkin lymphoma a world of its own? (2020) (0)
- P.18.4 USE OF AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STROMAL CELL (MSC) TRANSPLANTATION AS RESCUE THERAPY FOR ADULT AUTOIMMUNE ENTEROPATHY (2012) (0)
- Therapy-Related Myelodysplastic Syndrome Following Treatment for Childhood Acute Lymphoblastic Leukemia: Outcome of Patients Registered in the EWOG-MDS 98/06 Studies, (2011) (0)
- AML-099 Prolonged XPO1 Inhibition Is Essential for Optimal Anti-Leukemic Activity in NPM1-Mutated AML. (2022) (0)
- Paroxysmal Nocturnal Hemoglobinuria Clones in Children with Acquired Aplastic Anemia: A Multicentric Study (2012) (0)
- Abstract 4139: SNAI2 inhibition promotes myogenic differentiation and prevents tumorigenic features of embryonal rhabdomyosarcoma (2018) (0)
- C026 Childhood refractory cytopenia: clinical, hematological features and response to immunosuppression (2007) (0)
- Possible roads to improve hemophagocytic lymphohistiocytosis outcome. (2020) (0)
- Immune Reconstitution after Adoptive Infusion of BPX501 Cells (donor T cells transduced with iC9 suicide gene) in Children Given Alpha/Beta T-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT): Preliminary Phenotypic and Functional Results of a Phase I-II Trial (2015) (0)
- Treatment of Severe Aplastic Anaemia (SAA) with Antilymphocyte Globulin (ALG), Cyclosporine (CyA) and Granulocyte Colony Stimulating Factor (G-CSF) 5 μG vs 10 μG/Kg : A Gitmo Prospective Randomized Study. (2004) (0)
- Allogeneic peripheral blood progenitor cell transplants have clinical and cost benefits over bone marrow transplants for children with acute lymphoblastic leukemia (2001) (0)
- Treosulfan – fl udarabine – thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies (2020) (0)
- T Cell Immunotherapy for Immune Reconstitution and GVHD Prevention After Allogeneic Hematopoietic Stem Cell Transplantation (2015) (0)
- Biomarkers Predict Graft-Vs-Host Disease Outcomes Better Than Clinical Response after One Week of Treatment (2016) (0)
- Long-Term Treatment Outcome in IPEX Syndrome Patients: An International Multicenter Retrospective Study (2018) (0)
- Clinical pharmacokinetics of high dose busulfan in children undergoing bone marrow transplantation (1992) (0)
- [Bone marrow transplantation in the treatment of severe aplastic anemia]. (1991) (0)
- The Long Noncoding RNA BALR2 Controls Novel Transcriptional Circuits Involved in Chemotherapy Sensitivity of Pediatric Acute Myeloid Leukemia (AML) Blasts (2019) (0)
- MODL-23. DNA METHYLATION AND COPY NUMBER VARIATION PROFILE FOR CHARACTERIZATION OF PEDIATRIC BRAIN TUMOR PRIMARY CELL LINES (2020) (0)
- MSCs in Pediatric Hematopoietic Stem Cell Transplantation (2013) (0)
- PS952 NELARABINE AS SALVAGE THERAPY FOR PEDIATRIC PATIENTS WITH RELAPSED T-ALL (2019) (0)
- Refractory Cytopenia In Childhood (RCC) with Normal Karyotype Is Unlikely to Progress to Advanced MDS Under a Watch and Wait Strategy (2010) (0)
- LG-38MicroRNA PROFILING OF PEDIATRIC LOW-GRADE GLIOMAS (pLGGs) (2016) (0)
- subtype pediatric, cytogenetically normal AML, not restricted to FAB M7 fusion transcript is a novel common feature in CBFA2T3-GLIS2 (2014) (0)
- Autologous EBV-specific cytotoxix T lymphocytes for the treatment of EBV-related nasopharyngeal carcinoma (2005) (0)
- Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies (2018) (0)
- Study Design of a Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate Ruxolitinib Over BAT in Patients with Corticosteroid-Refractory Chronic Graft vs Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation (REACH-3) (2018) (0)
- Intrafistular Injection of AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS for the TREATMENT of Refractory Perianal CROHN'S DISEASE. (2009) (0)
- Guidelines for the Standardization of Acute Graft-Versus-Host Disease Clinical Data Collection: An International Consensus Report (2015) (0)
- MSCs in Pediatric Hematopoietic Stem Cell Transplantation (2013) (0)
- Response: Human cytomegalovirus DNAemia and preemptive treatment of HCMV infection in children receiving hematopoietic stem-cell transplantation (2008) (0)
- HSCT for chronic myeloproliferative disorders in children (2008) (0)
- OC.03.1 BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS (MSC) LOCALLY INJECTED FOR REFRACTORY FISTULIZING CROHN'S DISEASE MODULATE IMMUNOGLOBULIN PRODUCTION (2012) (0)
- P.78 BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS LOCALLY INJECTED INDUCE AN UP-REGULATION OF BOTH CIRCULATING AND MUCOSAL FOXP3+ REGULATORY T-CELLS IN PATIENTS WITH PERIANAL CROHN'S DISEASE (2010) (0)
- Myelodysplastic Syndromes Myelodysplastic syndromes : recent advances (2001) (0)
- Abstract 5347: Inhibition of Notch3 signaling reduces tumorigenic properties of human rhabdomyosarcoma cells (2011) (0)
- cause of Diamond-Blackfan anemia Mutations in the erythropoietin receptor gene are not a common (2011) (0)
- Safety of Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis: Results of the Primary Analysis of the Pivotal Phase 2/3 Study (2020) (0)
- Response: Imatinib in lung cGVHD of mild to moderate severity. (2009) (0)
- Patient-Derived Chimeric Antigen Receptor T-Cell Production Based on a Gammaretroviral Vector Platform Is Not Associated with Generation of CAR+ Leukemia Blasts (2018) (0)
- CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Factors Associated With Outcome After Cord Blood Transplantation in Children With Acute Leukemia (2016) (0)
- Peripheral blood stem cell collection from healthy donors for allogeneic transplantation. (1996) (0)
- 48 Gata2-Related Myelodysplastic Syndromes (Mds): Prevalence, Clinical Characteristics and Prognosis (2015) (0)
- Translocation 8/21 in myelodysplastic syndromes (1991) (0)
- Principles and Clinical Indications (2011) (0)
- αβT- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes (2022) (0)
- Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) in Children with Myelodysplastic Syndromes (2021) (0)
- Unrelated hematopoietic stem cell transplantation in thalassemia: Role of KIR polymorphism (2004) (0)
- patients with juvenile myelomonocytic leukemia Development of an allele-specific minimal residual disease assay for (2013) (0)
- C0545: Genetic Prothrombotic Factors in Children with Otogenic Lateral Sinus Thrombosis: Experience of an Italian Centre (2014) (0)
- Abstract 1922: miR-301 expression is deregulated in rhabdomyosarcoma (2016) (0)
- Management of Chronic Myeloid Leukemia in Children and Adolescents According to Local Guidelines.the Italian Experience (2016) (0)
- Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Franco Locatelli?
Franco Locatelli is affiliated with the following schools:
